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Cardiovascular diseases are the leading causes of death in the developed world. 
Atherosclerosis, a type of cardiovascular disease where blood vessels stiffen and 
accumulate lipid-laden plaques that restrict blood flow, is a major underlying cause of 
many cardiovascular events, including heart attack or stroke. The stiffening of blood 
vessels occurs also occurs with age, which is considered a significant risk factor for 
atherosclerosis. Although a relationship exists between age, vessel stiffening, and 
atherosclerosis, the exact mechanisms underlying this relationship are not well-
characterized.  
 
Herein, we demonstrate that age-related vessel stiffening promotes hallmarks 
of atherosclerosis, specifically endothelial permeability and vascular smooth muscle 
cell (VSMC) motility. Endothelial cells cultured on synthetic hydrogel substrates 
made to mimic the stiffness of healthy and diseased vessels exhibited increased 
permeability on stiffer substrates. This increase in permeability is due to the widening 
of endothelial cell-cell junctions and results in increased leukocyte transmigration 
through endothelial monolayers. Using a mouse model of aging, aged mice were also 
found to display increased vessel permeability and junction separation compared to 
young mice. Substrate stiffness induces endothelial permeability and junctional 
separation by upregulating cell contractility in a RhoGTPase-dependent manner. 
 Inhibition of cell contractility pharmacologically or with siRNA restored endothelial 
monolayer integrity in vitro and in vivo. 
 
In the later stages of atherosclerosis, VSMCs migrate into the intimal layer 
from the medial layer of the artery and contribute to the formation of atherosclerotic 
plaques. Age-related vessel stiffening mediates this migration, which is also 
stimulated by the release of platelet-derived growth factor (PDGF) by endothelial cells 
or entrapped inflammatory cells. PDGF also induces the formation of circular dorsal 
ruffles (CDRs), actin-based structures associated with enhanced cell motility. Herein, 
our data demonstrate that vessel stiffening promotes the formation of CDRs by 
increasing cell contractility and intracellular pre-stress. When VSMC contractility was 
enhanced or inhibited pharmacologically, cells significantly increased or decreased 
CDR formation, respectively. Together, our results suggest that extracellular matrix 
stiffening alone, which occurs during aging, can lead to endothelial monolayer 
disruption, VSMC motility, and atherosclerosis pathogenesis. Our data suggest that 
targeting vascular stiffening and/or cellular responses to stiffening may be a promising 
approach to preventing atherosclerosis. 
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CHAPTER 1 
 
INTRODUCTION 
 
Portions of this chapter were published as a book chapter titled “Cell Generated Forces 
in Tissue Assembly and Disease” in Mechanobiology of Cell-Cell and Cell-Matrix 
Interactions (Huynh et al., 2011) 
 
1.1 Atherosclerosis 
Cardiovascular diseases (CVDs) are the leading causes of death in the United States, 
accounting for approximately 800,000 out of 2.5 million deaths per year, or nearly 33 
percent (Roger et al., 2012). Atherosclerosis, a disease where blood vessels harden and 
thicken, is the underlying cause of CVDs (Frostegård, 2005; Noll, 1998). During the 
progression of atherosclerosis, white blood cells and fatty materials like low density 
lipoproteins (LDL) permeate through the endothelial cell (EC) layer and accumulate 
within the vessel wall (Ross, 1999). The release of cytokines and growth factors from 
endothelial cells and white blood cells stimulates the migration and proliferation of 
normally quiescent vascular smooth muscle cells (VSMCs) from the medial layer into 
the intima (Raines, 2004). This results in the formation of atherosclerotic plaques that 
occlude the vessel and restrict blood flow (Paraskevas et al., 2007). Rupture of these 
plaques often leads to the formation of thrombi, which can detach and block 
downstream blood flow (Badimon and Vilahur, 2012). This generally has severe 
consequences as the blockage of blood flow may lead to complications such as 
claudication, heart attack, and stroke.  
 
Atherosclerotic vessels have increased stiffness compared to healthy, native 
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vessels (Zoungas and Asmar, 2007). This increase in vascular stiffness is partially due 
to increased deposition of extracellular matrix (ECM) proteins collagen and 
fibronectin (Zieman et al., 2005), collagen cross-linking caused by the accumulation 
of advanced glycation end-products (Basta, 2008), and elastin fatigue and fracture 
(Greenwald, 2007; O’Rourke, 2007). In addition to atherosclerosis, vascular stiffening 
also occurs in a number of other pathologies, including hypertension (Laurent and 
Boutouyrie, 2007) and diabetes (Laugesen et al., 2009). 
 
Interestingly, vascular stiffening also occurs universally with age, which is 
considered a major risk factor for CVD. A recent study showed that aortic pulse wave 
velocities, a measurement of arterial stiffness, of healthy 85 year olds are double that 
of healthy 35 year olds (McEniery et al., 2005), clearly linking vascular stiffening to 
age. Additionally, according to recent statistics, only ~18% of CVD-related deaths 
occurred in people younger than 65 years of age, but ~67% of deaths due to CVDs 
occurred after the age of 75 (Roger et al., 2012). Atherosclerosis is found in half of the 
population over the age of 65. Notably, studies have shown that macroscale arterial 
stiffness, measured through pulse wave velocities, can independently predict 
cardiovascular events including coronary heart disease and stroke and are used for 
clinical diagnosis of cardiovascular risks (Blacher et al., 1999; Mattace-Raso et al., 
2006; Sutton-Tyrrell et al., 2005). To perform pulse wave velocity measurements, two 
probes are placed on the patient—generally, one at the carotid artery and another at the 
femoral artery. These probes sense the pulse through the arteries and calculate the 
speed of blood flow by using the distance between the two probes. The slower that the 
pulse wave velocity is, the more elastic and distensible the arteries are. Conversely, 
faster pulse wave velocities indicate stiffened vessels and increased risk for CVD 
(Boutouyrie et al., 2009).  
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While vascular stiffening correlates with cardiovascular risk, little is known 
about how changes in vascular stiffness affect the function of the endothelial and 
vascular smooth muscle cells in the vessel wall. It was not until more recently that 
platforms were developed to rigorously study the relationship between substrate 
stiffness and cell behaviors like adhesion, proliferation, migration, and differentiation. 
These platforms will be described in the following sections, along with an overview of 
the forces in cell-substrate and cell-cell interactions, methods to measure cell forces 
and mechanical properties, and the importance of forces in disease, particularly 
atherosclerosis. 
 
1.2 Biology of cell-cell and cell-substrate interactions 
1.2.1 Cell structures involved in mechanosensing 
Cell adhesions are critical for the maintenance and structure of tissues. Two families 
of structures that are important in mediating cell adhesions are cadherins and integrins. 
Cadherins are calcium-dependent transmembrane proteins that associate with cell-cell 
adhesions (Nishimura and Takeichi, 2009). Integrins, on the other hand, are 
transmembrane proteins that mediate cell-ECM interactions (Delon and Brown, 2007).  
Importantly, both cadherins and integrins are physically linked to actin (Aplin et al., 
1998), a major component of the cell cytoskeleton. Due to this linkage, crosstalk 
between cadherins and integrins are thought to regulate mechanotransduction during 
development (Schwartz and DeSimone, 2008) and disease progression (Jaalouk and 
Lammerding, 2009). 
 
 Within the vasculature, endothelial cells line the inner surface of blood vessels 
and control the permeability of cells and solutes into the underlying tissue. 
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Perturbation of the endothelial lining may result in pathological conditions such as 
edema (Chavez et al., 2011) and atherosclerosis (Hirase and Node, 2012). Vascular 
endothelial (VE)-cadherin regulates endothelial cell-cell adhesions by forming 
adherens junctions, zipper-like structures along the cell border than link ECs to one 
another (Dejana and Giampietro, 2012). In addition to mediating cell-cell interactions, 
VE-cadherin interacts with the cell cytoskeleton by binding to actin through regulatory 
or scaffolding proteins like α-catenin, β-catenin, p120, and plakoglobin (Dejana et al., 
2008). Interestingly, when VE-cadherin is phosphorylated at tyrosine residues, 
adherens junctions separate due to VE-cadherin degradation and internalization 
(Gavard, 2009), resulting in impaired endothelial barrier function. Because VE-
cadherin is linked to actin, actomyosin contraction is also believed to regulate cell-cell 
adhesions (Dudek and Garcia, 2001). 
 
Integrins are heterodimeric transmembrane proteins that are heavily involved 
in cell-substrate interactions. Although 18 α-subunits and 8 β-subunits have been 
identified in mammals, integrins only assemble into 24 different known pairs, each of 
which have specific interactions with different ECM proteins  (Margadant et al., 
2011). Two distinct mechanisms are involved in integrin signaling and activation. In 
“outside-in” signaling, the binding of integrins to its ligand or ECM causes a 
conformational change and activation of integrins. Conversely, in “inside-out” 
signaling, the binding of an intracellular activator, e.g. talin or vinculin, induces 
increased affinity of integrins for its ligand (Shattil et al., 2010). When activated, 
either by internal or external signals, integrins cluster at adhesion sites, growing in size 
and protein content from nascent focal complexes to focal adhesions (FAs) (Berrier 
and Yamada, 2007; Parsons et al., 2010).  
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Focal adhesions are particularly important in cell-matrix interactions and 
mechanotransduction (Chicurel et al., 1998; Katsumi et al., 2004; Maniotis et al., 
1997). This is partially due to their role in acting as a centralized point for downstream 
signaling cascades. Indeed, a large number of signaling proteins involved in cell 
migration and proliferation are recruited to FAs, including focal adhesion kinase 
(FAK) (Zhao and Guan, 2011), integrin-linked kinase (ILK) (Persad and Dedhar, 
2003), and Src (Kim et al., 2009). In addition to their role as signaling hubs, FAs 
connect the actin cytoskeleton to the underlying ECM (Shattil et al., 2010).  
 
Actin is a ~42 kDa protein that exists in two forms in the cell: globular 
monomeric actin (G-actin) and filamentous actin (F-actin). G-actin can bind ATP to 
form a stable core which becomes the basis for spontaneous F-actin polymerization 
(Dominguez and Holmes, 2011). Bundles of F-actin, or stress fibers, are critically 
important in determining cell shape and contractility (Ingber, 2003; Pellegrin and 
Mellor, 2007). When treated with cytochalasin D, an inhibitor of actin polymerization, 
cells lose their structural integrity and ability to remain well-spread (Kraning-Rush et 
al., 2011). Myosin motor proteins interact with stress fibers to provide contractile 
forces within cells which are then transmitted to the ECM as traction forces (Kumar et 
al., 2006). As will be reviewed later in this chapter, traction forces are essential for 
many cell behaviors including migration, differentiation, and disease.  
 
1.2.2 Signaling pathways involved in mechanosensing 
 The Rho family of guanosine triphosphatases (GTPases) is a family of G 
proteins that are intricately involved in actin cytoskeletal organization (Bishop and 
Hall, 2000) and  the generation of cell contractile forces (Huang and Ingber, 2005). As 
a G protein, RhoGTPase acts as a molecular switch—it is active or inactive when 
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bound to GTP or GDP, respectively. Rho guanine exchange factor (RhoGEF) 
associates Rho with GTP so that active Rho can associate with and stimulate different 
effector proteins. Rho GTPase-activating protein (RhoGAP) hydrolyzes GTP to GDP, 
returning Rho to an inactive state.  
 
To control actin dynamics, RhoGTPase associates with its effector, Rho-
associated kinase (ROCK) to control the activity of downstream myosin (Narumiya et 
al., 2009). ROCK serves a dual purpose to elicit actomyosin contraction. Firstly, 
ROCK inactivates myosin light chain (MLC) phosphatase, which inhibits the 
dephosphorylation of MLC resulting in increased levels of phosphorylated MLC. 
Secondly,  ROCK can phosphorylate MLC directly (Amano et al., 2010). Together, 
ROCK activity induces MLC phosphorylation which stimulates the association of 
myosin with stress fibers and increases actomyosin contraction.  
 
1.2.3 Measuring cell forces  
Cadherins, integrins, and actin are physically linked within the cell, and their 
interplay is crucial to controlling cell contractility and traction force generation 
(Kumar et al., 2006). Traction forces have been implicated in regulating a variety of 
cell behaviors (Chen, 2008; Discher et al., 2005; Orr et al., 2006; Vogel and Sheetz, 
2006). Endogenous traction forces are used for motility, tissue assembly, ECM 
remodeling, and mechanosensing. In recent years, many different methods have been 
developed to quantify cellular traction forces. Here, I will briefly describe these in 
vitro methods and highlight the experiments that have characterized the nature of 
traction forces. 
 
 The first observations of traction forces were published by Harris and 
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colleagues in 1980. Using deformable silicone rubber substrates, they captured images 
of fibroblasts forming wrinkles in the substrate (Figure 1.1A), indicating the 
generation of inward forces strong enough to deform their substrate (Harris et al., 
1980). Interestingly, there was no evidence of pushing forces based on the location of 
the cell relative to the wrinkles. The most significant drawback to the wrinkling 
substratum method, despite its ease to implement, is that it is only semi-quantitative. It 
is difficult (and perhaps impossible) to derive quantitative information about the 
magnitude of the forces based on the location or size of the wrinkles. This limitation 
was overcome by the incorporation of fluorescent beads into pre-stressed silicone 
substrates, which provided a more quantitative analysis of cellular traction forces (Lee 
et al., 1994) and set the stage for methods of measuring force through substrate 
displacement analysis. Regarded as an inverse problem where cell-generated stress is 
calculated from the measurement of underlying substrate displacement, one particular 
method for measuring traction forces from substrate displacements has gained 
prominence in recent years: traction force microscopy. 
 
Traction force microscopy (TFM) was developed by Dembo and coworkers to 
measure cell-generated traction stresses (Dembo et al., 1996). Using images of 
fluorescent bead fields before and after a cell is released by trypsinization, TFM 
calculates bead displacements through an optical flow algorithm (Marganski et al., 
2003). As mentioned above, these displacements can then be used to inversely 
calculate force generation based on the stiffness of the substrate to which cells are 
attached  (Figure 1.1D-H) (Dembo and Wang, 1999). TFM algorithms by Dembo et al. 
have been packaged in a licensed software library called LIBTRC. Similar techniques 
that also solve the inverse problem have been published by others in recent years (Del 
Alamo et al., 2007; Butler et al., 2002; Sabass et al., 2008). 
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Figure 1.1. (A) Landmark experiments with chick heart fibroblasts on deformable 
silicone substrates reveal the presence of cell-generated traction forces; bar is 100 µm. 
From Harris et al. (1980). (B) and (C) Micropost arrays: (B) Electron micrograph of a 
smooth muscle cell attached to a microfabricated post array. (C) Traction force vector 
map (white arrows) obtained by measuring post deflections spatially correlated with 
immunofluorescence localization of the focal adhesion protein vinculin (green); bars 
are 10 µm, arrow is 50 nN. From Tan et al. (2003). (D-H) Traction force microscopy: 
(D) A cell is plated on a deformable substrate and imaged with phase contrast 
microscopy. Fluorescent beads embedded in the gel substrate are imaged immediately 
after the phase image (e, “Stressed”) and after cell removal with trypsin (f, “Null”).  
(G) Merged fluorescent images depict the displacements of the marker beads in the 
substrate due to cell contractile forces in the boxed region of the phase image. (H) 
Marker displacements are used to calculate the magnitude (|T| per area) and direction 
(arrows) of tractions that a cell exerts on the substrate. Scale bar in (D-G) is 50 µm; 
beads in (D-G) are 0.5 μm in diameter. From Califano and Reinhart-King (2010). 
Reprinted with kind permission of Springer Science and Business Media. 
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A second prominent method for measuring traction, first described by Tan  and 
coworkers (Tan et al., 2003), involves cell culture on microfabricated post array 
detectors (mPADs, Figure 1.1B and C) (Sniadecki and Chen, 2007). Cell force and 
contractility causes the posts to deflect. These deflections are directly proportional to 
the traction forces exerted by the cell and are calculated at each post using elastic 
beam theory (Tan et al., 2003). The modulus of mPADs can be altered by the 
geometry of the posts independent of the surface ECM coating that facilitates cell 
adhesion. The advantage of such a technique is that computationally, cellular forces 
are straightforward to calculate, as the calculation is based on simple beam-bending 
mechanics. Moreover, the force on each post is decoupled. A drawback of these 
measurements is that the cells are adherent to a non-continuous surface, which 
deviates further from mimicking the in vivo environment. 
 
Alternate methods of force quantification have also been described, including 
the use of microfabricated cantilevers (Galbraith and Sheetz, 1997) and 
micropatterned silicone elastomeric substrates (Balaban et al., 2001), but their 
appearance in the literature is limited. 
 
1.3 Cell-substrate and cell-cell interactions mediate cell forces 
1.3.1 Cell-substrate interactions mediate force generation 
Traction force generation is sensitive to a variety of factors, including cell shape, cell 
size, ECM density, substrate stiffness, and growth factors present in the environment. 
Early work showed that traction generation is dependent on both cell shape and size 
(Parker et al., 2002; Wang et al., 2002). In these studies, cells were cultured on 
adhesive islands of different shapes to understand how cell shape affects traction force 
generation. The authors find that tractions on circular islands were greatest at sites of 
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cell protrusion but exhibit no preferred direction of force. However, on square islands, 
the highest tractions are associated with protrusions at the square corners, implicating 
shape to be an important mediator of traction force generation. In regards to cell size, 
Lemmon and co-workers performed a comprehensive study of traction force 
measurements across numerous cell types, including smooth muscle cells, endothelial 
cells (ECs), fibroblasts, and epithelial cells. While the magnitude of traction forces 
between cell types varied significantly, within each cell type traction forces increased 
with cell size (Lemmon et al., 2005), underscoring the importance of cell size and 
spreading to traction force generation. Work in our lab also shows that traction forces 
increase linearly with cell area (Reinhart-king et al., 2003). 
  
Traction forces are also sensitive to substrate ECM coating and stiffness. On 
polyacrylamide gels derivatized with increasing concentrations of ligand, cells exhibit 
increased spreading and higher traction forces on substrates with higher ligand 
concentration (Reinhart-King et al., 2005). It is hypothesized that additional ligand on 
a surface increases the availability of cell-matrix adhesions to form, thereby increasing 
focal adhesion formation and cell contractility. Cellular force also increases with 
substrate stiffness and concomitant increases in cell area (Lo et al., 2000; Paszek et al., 
2005). Since increasing substrate stiffness increases contractility and cell area, 
interplay between substrate stiffness, cell area, and traction force generation may exist. 
Using measurements of force, area, and stiffness coupled with linear regression 
modeling, our lab demonstrated that both substrate stiffness and cell area are 
significant predictors of traction force generation. (Califano and Reinhart-King, 2010). 
Together, these data suggest that both substrate stiffness and cell area, whether 
modulated by stiffness directly or by ligand density, contribute significantly to traction 
force generation.  
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Interestingly, growth factors present in the extracellular environment also 
modulate cell contractility (Ren et al., 1999). For example, vascular endothelial 
growth factor (VEGF), a secreted glycoprotein that stimulates endothelial cell 
proliferation, migration (Leung et al., 1989), and angiogenesis (Nicosia, 1998) has 
been shown to stimulate stress fiber and focal adhesion formation (Huot et al., 1998) 
through RhoGTPase and ROCK activation (van Nieuw Amerongen et al., 2003). 
Similarly, tissue growth factor-α (TGF-α), a ligand for epidermal growth factor 
receptors, stimulates RhoGTPase and ROCK activity that lead to cytoskeletal 
reorganization (Appleton et al., 2010). While growth factors are typically only 
considered in the context of their effects on cell growth on proliferation, these data 
indicate that they may function in part through their ability to alter cell contractility 
profiles. It is likely that there is significant crosstalk between cell response to growth 
factors, substrate stiffness, and cell-matrix adhesions, suggesting that these separate 
signals integrate intracellularly to produce a specific cell response. 
 
In addition to “outside-in” events that cause cells to alter their force generation, 
“inside-out” events occur where cell-matrix adhesions transmit force from the cell to 
the substrate. Real-time measurements of cell force coupled with fluorescent imaging 
of focal adhesions indicate that focal adhesion area is linearly dependent on the local 
force exerted by a cell (Balaban et al., 2001). This relationship indicates that a 
constant stress is applied to focal adhesions in the cell despite variations in focal 
adhesion size and shape. Separate experiments with cells on mPADs confirm that cell-
generated stresses onto their substrate correlate with focal adhesion size (Tan et al., 
2003). Less mature focal complexes at the leading edge of a cell are capable of 
exerting strong transient forces that drive migration (Beningo et al., 2001). Forces 
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subsequently decrease as adhesions mature into large plaques that become centrally 
localized in the cell during migration. More recent work further illustrates the complex 
interaction of force generation and substrate adhesions. When 3T3 fibroblasts are 
seeded on magnetic microposts and deflected by an external magnetic field, changes in 
traction forces occur at peripheral adhesions that are located further away from the 
force application site (Sniadecki et al., 2007). These data suggest that cells can 
respond to an “outside-in” mechanical signal at one location and transmit cell-
generated traction forces “inside-out” at another location. It is hypothesized that 
mechanical signals can be transmitted throughout the cytoskeleton, but the exact 
mechanism remains unknown. Together, these data emphasize the complex interplay 
between “outside-in” and “inside-out” signaling that controls mechanotransduction 
and force generation. 
 
1.3.2 Cell-cell interactions mediate force generation 
While much of the work investigating cellular traction forces have focused on cell-
matrix contractility, recent work has adapted traction force microscopy methods to the 
study of forces exerted at cell-cell contacts as well (Ganz et al., 2006). Cadherins are 
intimately linked to intracellular signaling mechanisms that influence cellular 
contractility and force generation. For example, vascular endothelial (VE)-cadherin 
mediated cell-cell contact activates a RhoGTPase signaling pathway, resulting in 
increased intracellular tension (Nelson et al., 2004) and time-dependent adhesion 
strengthening (Kris et al., 2008). Interestingly, this cadherin-mediated increase in 
contractility is actin dependent, similar to integrin-mediated contractility. 
 
Cadherins are capable of mediating cellular contractility, and there is growing 
interest in measuring these forces. To do this, recent work has coated deformable 
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substrates with cadherin fragments, thereby simulating cell-cell contacts on a matrix 
used for traction measurements. Cadherins directly transmit traction forces (Ganz et 
al., 2006; Ko et al., 2001) that increase with increasing substrate rigidity and require 
actomyosin activity (Ladoux et al., 2010). These data implicate cadherins as integral 
components of cellular mechanosensing.     
 
1.4 Cell-matrix and cell-cell interactions in development, migration, and disease 
1.4.1 Matrix stiffness regulates development and differentiation 
Matrix rigidity, which plays a large role in the generation of traction forces, also plays 
a critical role in development, differentiation, and tissue formation. In a seminal study 
by Engler and co-workers, substrate stiffness alone has been found to direct 
differentiation of mesenchymal stem cells (MSCs) (Engler et al., 2006). When plated 
on substrates that have a rigidity similar to that of brain tissue, MSCs are directed into 
a neurogenic lineage, whereas on stiffer substrates that mimic the rigidities of muscle 
or collagenous bone, MSCs differentiate into myogenic or osteogenic lineages. 
Similarly, substrate elasticity has been found to modulate cell spreading, growth rate, 
gene expression, and osteogenic differentiation of pluripotent embryonic stem cells 
(Evans et al., 2009).  
 
In addition to changes in ECM stiffness, the stiffness of cells themselves also 
contributes to differentiation and embryogenesis. Notably, the nuclei of human 
embryonic stem cells stiffens six-fold as cells progress through differentiation 
(Pajerowski et al., 2007), suggesting that cell stiffening plays a role in promoting 
differentiation. Chowdhury et al. corroborated this finding by showing that mouse 
embryonic stem cells are ten times softer than their differentiated counterparts 
(Chowdhury et al., 2010). It has been hypothesized that by remaining soft, 
 15 
undifferentiated cells have the advantage of being more motile and retain the ability to 
migrate through solid tissues and small pores.  
 
Cell stiffness is directly influenced by the actomyosin-dependent contraction of 
cells (Krieg et al., 2008). Sordella and coworkers show that modulating the activity of 
RhoGTPase, an integral mediator of cell force generation, is sufficient to alter the 
differentiation program of adipocyte and myocyte precursors (Sordella et al., 2003). 
The authors also show that mouse embryo-derived fibroblasts lacking p190RhoGAP, 
an inhibitor of RhoGTPase, have excessive Rho activity and are defective for 
adipogenesis, opting instead to undergo myogenesis. Subsequent studies suggest that 
actomyosin-dependent tension, mediated by Rho and its downstream effector Rho-
associated kinase (ROCK), is required for human MSCs to commit to osteogenesis 
(McBeath et al., 2004). McBeath and coworkers attribute lineage commitment to 
mechanical cues presented by changes in cell shape—they found that unspread, round 
MSCs underwent adipogenesis whereas flat, spread cells committed to an osteogenic 
lineage.  
 
In vivo studies also implicate the Rho-ROCK pathway as a central facilitator of 
differential growth in tissue assembly. In embryonic mouse lung morphogenesis, 
disrupting cell tension by inhibiting ROCK and other downstream effectors alters 
basement membrane thickness, inhibits new epithelial bud formation, and disrupts 
capillary blood vessels (Moore et al., 2005). Conversely, increasing cell tension by 
activating RhoGTPase accelerates lung branching and increases capillary elongation. 
Taken together, these studies highlight the critical role cell-generated forces play in 
the correct differentiation of stem cells and embryonic development. 
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1.4.2 Cell-generated forces regulate cell motility, migration, and proliferation 
One of the core functions of traction force generation is to drive cell motility (Oliver et 
al., 1999), a process that is necessary during cell organization and tissue assembly. 
Differential motility among cell types is responsible for cell sorting and self-
organization in tissues (Mori et al., 2009). Local ECM chemistry and mechanics that 
affect cell-generated forces are likely responsible for the differential motility of cells 
during development and assembly. Early experiments indicate that changes in cell 
migration may be attributed to substrate ligand density, integrin expression level, and 
ligand binding affinity (Palecek et al., 1997). Other studies show that in addition to 
substrate ligand density, substrate stiffness also mediates cell migration (Jannat et al., 
2010; Peyton and Putnam, 2005). The phenomenon of durotaxis, where cells migrate 
in response to a stiffness gradient, was identified a decade ago in fibroblasts (Lo et al., 
2000). More recent work with bovine aortic smooth muscle cells indicates that 
durotaxis and cell orientation increase with increasing stiffness gradient magnitude 
(Isenberg et al., 2009). Although more research is necessary to fully understand the 
role of substrate mechanics in cell migration, it is a clear parameter in dictating cell 
locomotion.  
 
While much of the work in elucidating the role of cell forces in migration has 
been performed with single cells, there is also a significant role for traction generation 
in collective cell migration. Collective cell migration, the phenomenon of migration of 
cell groups (Rorth, 2007), occurs during development, wound healing, and metastasis. 
Less is known about traction forces in cell aggregates, largely because few techniques 
exist to make these measurements. Early work has been done to investigate collective 
cell migration and traction force generation in Madin-Darby canine kidney (MDCK) 
cell epithelial sheets as a model system for the epithelial-mesenchymal transition  (de 
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Rooij et al., 2005). de Rooij and colleagues show that epithelial cell scatter, which 
recapitulates cancer cell invasion and metastasis, of MDCK cells increases with 
increasing concentrations of ECM protein and correlates with adhesion strength and 
actomyosin-dependent contractility. This contractility transmits tension to the cell 
periphery.   
 
du Roure and co-workers expanded on these studies and measured traction 
forces of MDCK cell sheets on microfabricated PDMS pillars. They find that traction 
stresses are greatest at the monolayer edge and are greater than those measured in 
single cells (du Roure et al., 2005). Separate work indicates that large traction forces 
are also generated in the bulk of the cell sheet, many cell rows away from the leading 
edge (Trepat et al., 2009). These traction forces may act in a global tug-of-war that 
pulls the cell sheet toward the leading edge. Additional work on PDMS substrates of 
anisotropic stiffness indicate MDCK cells assembly is anisotropic along the stiffest 
substrate direction and correlates with traction force and actin cytoskeletal orientation 
(Saez et al., 2007). These data indicate that cells within cell sheets can act in concert to 
generate traction forces throughout the tissue and further implicate substrate stiffness 
as a regulator of tissue formation. As this is a nascent area, much work remains to be 
done to understand the role of traction generation in collective cell movements, and 
new technologies are required to investigate and quantify collective forces. 
 
During tissue formation, cells migrate and proliferate into new structures. Cell-
generated forces are critically important during cell proliferation and division (Scholey 
et al., 2003). The same interplay described earlier of cell-substrate and cell-cell 
interactions also mediates proliferation of cells within cell aggregate models of tissues. 
Recent work suggests that differential patterns of proliferation correspond to local 
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mechanical stresses and cytoskeletal generated tension. Localized cell proliferation 
within cell aggregates were found to correspond to regions of high traction stresses 
generated within a cell monolayer (Nelson et al., 2005). Additionally, inhibition of 
actomyosin contraction or cadherin-mediated adhesions disrupted the spatial pattern of 
proliferation. In similar experiments, fibroblast proliferation and differentiation on 
micropatterned PDMS islands correspond to high levels of mechanical stress at the 
perimeter of cell aggregates (Li et al., 2009). These data indicate that tension at the 
cell-matrix interface and along the edges of collections of cells can drive proliferation 
profiles. 
 
Forces generated through cell-cell contacts also regulate proliferation. A 
biphasic proliferative response is seen when cell proliferation is regulated by the 
amount of neighboring-cell contact: while a single-cell neighbor increases 
proliferation, an increasing number of contacting cells inhibits proliferation (Gray et 
al., 2008). This relationship is potentially explained by the balance that exists between 
contractility, spreading, and proliferation. While increases in proliferation are 
dependent on RhoGTPase-mediated intracellular tension, cell-cell contacts may lower 
proliferation by decreasing cell-ECM contact. Using ECs cultured on patterned PDMS 
substrates, Nelson and Chen show that VE-cadherin-mediated cell-cell contact 
promotes opposing proliferation signals (Nelson and Chen, 2003). VE-cadherin 
inhibits cell spreading and proliferation when cells are physically constrained; 
otherwise, VE-cadherin increases proliferation through Rho-dependent changes in 
cytoskeletal tension. These data again point to the delicate balance between cell-
matrix and cell-cell adhesion in regulating cell behavior.  
 
1.4.3 Cell-generated force disruption in disease and atherosclerosis 
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Other than the hematopoietic cells, all cell types require adhesion for normal function.  
As such, virtually all cell types are capable of generating forces and sensing their 
mechanical environment. When cell-generated forces are altered due to changes in the 
mechanical properties of their microenvironment, cell functions such as survival, 
death, proliferation, adhesion, and migration may become dysregulated. The 
perturbation of proper force balance or mechanotransduction signaling pathways is 
thought to result in diseases of the liver (Wells, 2008), heart (Lammerding et al., 
2004), and vasculature (Haga et al., 2007), among others. Importantly, changes in 
ECM elasticity and the disruption of force balance are also considered important 
factors in cancer progression (Butcher et al., 2009).  
 
As an example of cell-force in disease progression, the tumor environment 
itself is stiffer than its surrounding tissue due to elevated interstitial fluid pressure, 
increased matrix deposition, and cell proliferation (Huang and Ingber, 2005). 
Currently, there is an emphasis in cancer research on elucidating the mechanical 
mechanisms that drive tumor progression and metastasis. In a study by Paszek and 
colleagues, increased RhoGTPase-dependent cell contractility, mediated by matrix 
stiffness, was found to disrupt tissue organization and enhance the malignant 
transformation of mammary epithelial cells (Paszek et al., 2005). Of note, reducing 
cytoskeletal tension by inhibiting Rho decreased tumor colony size and proliferation 
and the expression of the malignant phenotype. These data were critical in establishing 
the role of matrix stiffness and cell-generated forces in abnormal cell growth and 
tumorigenesis. 
 
Oftentimes, the mechanical compliance of tissues is altered in injury. After 
injury of the skin, for instance, platelets aggregate and form a temporary fibrin clot, 
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and myofibroblasts lay down a provisional ECM comprised of collagen (Midwood et 
al., 2004). Although myofibroblasts quickly restore the mechanical integrity of 
damaged tissues, scar tissues have increased stiffness due to excessive collagen 
deposition, or fibrosis (Hinz, 2009). Unfortunately, fibrosis after injury can affect 
almost every organ in the body. For example, recent studies investigated the effects of 
matrix rigidity on cell differentiation in the early stages of liver fibrosis. Li et al. show 
that myofibroblastic differentiation of liver portal fibroblasts depends on mechanical 
tension and that they exhibit increasingly myofibroblastic phenotypes with increasing 
matrix rigidity (Li et al., 2007). Subsequent in vivo studies confirmed that liver 
stiffness is influenced by matrix quantity and cross-linking (Georges et al., 2007). This 
increase in stiffness was found to precede liver fibrosis and is thought to activate 
myofibroblast differentiation. 
 
In the cardiovascular system, myocardial infarction is generally followed by 
scarring of the heart tissue and fibrosis, which leads to increased stiffness and 
impaired cardiac output. To compensate for this decrease in cardiac output, 
cardiomyocytes increase in size in order to generate more force, which leads to 
increased ventricular wall thickness or dilation (Grossman et al., 1975; Sun and 
Weber, 2000). Over time, elevated stress levels in the myocardium leads to the 
dysregulation of ECM remodeling resulting in myocyte apoptosis, necrosis, and 
cardiac failure (Barry et al., 2008; Jaalouk and Lammerding, 2009). Interestingly, 
optimal beating of cardiomyocytes has been found to correspond to an optimal matrix 
elasticity (Engler et al., 2008). Engler and colleagues cultured chick embryonic 
cardiomyocytes on substrates of varying compliances and observed significant 
differences in cardiac output and strength of beating. On stiffer matrices that mimic 
the modulus of fibrotic myocardium, large differences were found between cell strains 
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and their underlying matrix strains, suggesting that cells were overstretching and 
overstraining themselves. Furthermore, cardiomyocytes on stiffer substrates rarely 
exhibited the typical striated myofibrils throughout the cytoplasm, and 48 hours after 
plating, less than 10% of cells continued to beat, with cells only beating sporadically  
(Engler et al., 2008). In comparison, cardiomyocytes on substrates softer than striated 
muscle were able to continuously beat but performed very little contractile work. 
These results show that for cells to function properly, they must be supported by a 
matrix of physiologic stiffness and may lose their native phenotype on matrices that 
are either too soft or too stiff, as occurs in many pathologies.  
 
Disruptions in cell-generated forces also have wide implications in disease 
progression of the vasculature, particularly in the development and advancement of 
atherosclerosis. Atherosclerosis is a multi-stage disease in which fatty deposits 
accumulate on the vessel wall and obstruct blood flow (Figure 1.2). Additionally, the 
artery stiffens, losing its elasticity due to excess ECM protein deposition by fibroblasts 
and smooth muscle cells (Zieman et al., 2005). Studies also suggest that advanced 
glycation end-products contribute to artery stiffening by crosslinking ECM proteins, 
particularly collagen, in the vessel walls (Soldatos and Cooper, 2006).  
 
The endothelial cell layer, normally a non-adhesive and non-thrombotic 
surface, is considered the first mediator in atherosclerosis progression. Dysregulation 
of the EC layer leads to increased permeability, immune cell attachment and lipid 
deposition. Force balance, driven by the mechanical interaction between the 
endothelium and its basement membrane (Figure 1.2A), is implicated as a critical 
factor in the maintenance of a functional endothelial barrier (Ingber, 1997; Mehta and 
Malik, 2006).   
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Figure  1.2. Disruption of force balance in the progression of atherosclerosis. (A) 
Increased vessel stiffness, particularly the rigidity of the internal elastic lamina, may 
disrupt endothelial cell force balance leading to increased cell contractility and barrier 
permeability. (B) Increased substrate and endothelial cell stiffness may recruit 
monocytes to adhere and transmigrate through the endothelial layer. (C) Increased 
ECM deposition and vessel stiffness causes vascular smooth muscle cells to proliferate 
and migrate into the intima, occluding the blood vessel. Reprinted with kind 
permission of Springer Science and Business Media. 
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It is hypothesized that RhoGTPase-dependent contractile forces drive ECs to 
separate, while cell-cell interactions provide tethering forces that maintain endothelial 
barrier integrity. In a recent study by Birukova et al., AFM was used to test this 
hypothesis by measuring the stiffness of human pulmonary artery ECs as they were 
stimulated with known barrier-disruptive or barrier-protective agonists (Birukova et 
al., 2009). The authors were able to show that barrier-disruptive agonists increase cell 
stiffness in the central region, while barrier-protective agonists increase stiffness at the 
cell periphery and decrease cell stiffness at the center. These results were confirmed 
by similar AFM studies on human umbilical vein ECs that show that cell stiffness and 
membrane tethering forces are directly related to the polymerization state of actin 
(Cuerrier et al., 2009). These results support the hypothesis that cell-generated forces 
maintain the endothelial barrier and directly link cell stiffness with specific 
permeability responses.  
 
As the permeability of the endothelium becomes dysregulated, lipoprotein 
deposition initiates the inflammation cascade and recruits immune cells to attach and 
transmigrate through the endothelial layer (Figure 1.2B). The adhesion and migration 
of neutrophils are influenced in part by cell-generated forces and substrate rigidity 
(Oakes et al., 2009). Neutrophils are more well-spread and exert greater traction forces 
when allowed to adhere to stiffer substrates. Additionally, neutrophils migrate more 
slowly on stiffer substrates but also more persistently, resulting in longer distances 
being covered. Further studies show that a balance in cell-generated force 
corresponding to an optimal substrate stiffness maximizes neutrophil migration 
(Stroka and Aranda-Espinoza, 2009). These in vitro data suggest that matrix 
stiffening, which occurs in atherosclerosis, may promote leukocyte recruitment and 
promote the inflammatory cascade in vivo. 
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Interestingly, in this same inflammatory cascade, heterogeneous cell-cell 
interactions alter cell mechanics. The adhesion of neutrophils to the EC layer increases 
the stiffness of adjacent ECs (Kang et al., 2009). When taken together with the 
findings of Birukova et al. which suggest that cell-generated forces may regulate 
endothelial permeability, it is possible that neutrophil adhesion causes a local increase 
in endothelial force generation and barrier permeability in preparation for their 
eventual transmigration. This possibility was explored in an elegant study done by 
Rabodzey and colleagues. The authors measured the tangential forces exerted by 
neutrophils during transmigration through a confluent EC layer grown on a 
microfabricated pillar substrate (Rabodzey et al., 2008). In response to neutrophil 
transmigration, endothelial cell-cell junctions become disrupted and EC traction forces 
increase significantly. Moreover, traction forces induced by neutrophil transmigration 
increase with increasing substrate rigidity. Therefore, the relationship between matrix 
stiffness, EC stiffness, and EC force generation plays an integral role in regulating 
permeability and transendothelial migration.  
 
In the later stages of atherosclerosis, vascular smooth muscle cells migrate 
from the media into the intima, largely contributing to the occlusion of the blood 
vessel (Figure 1.2C). Coincident with this migration is an increase in collagen 
deposition and increased vessel stiffness. Recent in vitro studies indicate that substrate 
stiffness has a direct effect on the migration speeds of VSMC. Data show that VSMC 
migration speed has a biphasic relationship with respect to substrate stiffness, 
suggesting that an optimal stiffness exists which maximizes cell migration speed and 
persistence (Peyton and Putnam, 2005). On substrates fabricated to contain well-
defined stiffness gradients (Isenberg et al., 2009), VSMCs orient themselves in the 
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direction of the gradient and preferentially migrate from softer to stiffer regions in a 
phenomenon termed durotaxis. While these studies have advanced our understanding 
of the interplay between mechanics and cardiovascular disease, additional attention is 
required to fully understand the role of cell-generated forces in endothelial 
permeability, neutrophil transmigration, and VSMC migration in vivo. 
 
1.5 Organization of the dissertation 
The objective of this work is to elucidate the mechanical mechanisms that underlie to 
progression of atherosclerosis. Specifically, I studied how substrate stiffness and cell 
contractility affect critical events that occur during atherosclerosis, such as endothelial 
permeability and vascular smooth muscle cell migration. Herein, I present data that 
implicate vascular stiffening as an important factor that may initiate and exacerbate 
atherosclerotic phenotypes. 
 
 In Chapter 2, I describe a novel method to measure the permeability of 
endothelial cells that are cultured on soft, porous substrates that better mimic vessel 
stiffness compared to conventional permeability measurement platforms. Because 
endothelial permeability assays are traditionally performed on tissue culture plastic, I 
first developed a method to measure permeability of cells cultured on polyacrylamide 
gels. Due to polyacrylamide’s porous nature, I developed an assay based on the 
accumulation of a fluorescently-labeled tracker molecule into the gels. We find that 
when polyacrylamide gels are immersed in a FITC-dextran solution, confocal 
microscopy can be used to image the amount of dye entrapped within the gel. When 
cells were grown to confluence on the gels, significantly less dye moved into the gel, 
indicating that endothelial cells were creating barrier that resisted the movement of 
dye. The method was then rigorously validated by treating endothelial cells with a 
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variety of known agonists to elicit permeability responses.  
 
 In Chapter 3, I use the method developed in Chapter 2 to determine the effects 
of substrate stiffness on endothelial permeability. Because the adherens junctions 
between endothelial cells are comprised of VE-cadherin, I studied their VE-cadherin 
organization in response to the stiffness of their substrate. In collaboration with the 
Schaffer Lab at Cornell, we also investigated permeability and VE-cadherin 
organization in a mouse model and found that permeability and VE-cadherin 
separation increases in aged, stiffer arteries. Moreover, using traction force 
microscopy, I present data that increased permeability and junction destabilization are 
the result of upregulated cell contractility. Notably, when endothelial cells were 
treated with a pharmacological inhibitor of cell contractility, permeability and junction 
separation were decreased. Importantly, we were able to recapitulate these results in 
vivo, where mouse permeability and VE-cadherin separation also decreased due to 
drug treatment. Lastly, in collaboration with the King Lab, we determined that 
leukocyte transmigration through endothelial monolayers increases with substrate 
stiffness, and inhibition of endothelial contractility reduces transmigration. These 
impactful results provide us with a better understanding of the relationship between 
age, vascular stiffening, and atherogenesis.  
 
 In Chapter 4, I present novel findings that substrate stiffness induces the 
formation of circular dorsal ruffles (CDRs) in vascular smooth muscle cells. Although 
these transient actin-based structures have been documented for many years, little is 
known if substrate stiffness affects their formation or function. Because they are 
widely assumed to play a role in mediating cell motility, we hypothesized that CDR 
formation may play a role in VSMC migration phenotypic of atherosclerotic plaque 
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formation. I show that more VSMCs exhibit CDRs on stiffer substrates and cell-
generated forces are required for robust CDR formation. When treated with activators 
and inhibitors of myosin light chain, cells form more or fewer CDRs, respectively. 
Additionally, the pathways that regulate CDR formation in response to substrate 
stiffness involve the association of Src and myosin light chain kinase (MLCK). 
 
 In Chapter 5, my experience as a NSF GK-12 teaching fellow is described. 
During this time, I developed and executed two high school level science labs at 
Waverly High School in Waverly, NY. These labs were aimed to teach polymer 
science and arterial stiffening to rising juniors. Additionally, I developed several 
lectures that were given to students to stimulate interest in science, technology, and 
biomedical engineering. Conclusions of my dissertation and future directions of 
research are presented in Chapter 6. Experimental protocols and GK-12 teaching 
materials are provided in the appendices. 
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CHAPTER 2 
 
REAL-TIME PERMEABILITY MEASUREMENTS OF ENDOTHELIAL 
MONOLAYERS ON SOFT SUBSTRATES 
 
Portions of this chapter were published in Science Translational  
Medicine (Huynh et al., 2011). 
 
2.1 Abstract 
Endothelial monolayer permeability is a hallmark of endothelial cell dysfunction and 
atherosclerosis. Multiple methods exist to measure monolayer permeability, but all 
have their limitations. Most notably, current in vitro methods involve placing cells on 
relatively stiff polycarbonate membranes which do not accurately recapitulate the 
mechanical environment of the endothelium in vivo. Here we describe a novel method 
to study the permeability of endothelial cells using substrates which mimic the 
physiological stiffness of the in vivo microenvironment. Using confocal microscopy, 
we devised a technique to monitor the movement of FITC-conjugated dextran through 
bovine aortic endothelial cell (BAEC) monolayers seeded on deformable 
polyacryalmide hydrogels made to mimic the stiffness of the endothelial basement 
membrane. We validated our technique by measuring the permeability of confluent 
BAECs after treatment with several different agonists and enhancers of permeability. 
Additionally, we show that permeability of BAEC monolayers is significantly 
enhanced when cultured on stiff substrates outside the range of physiological 
relevance, like those used in traditional permeability assays. These results underscore 
the need to measure permeability using methods that more closely mimic the in vivo 
environment. Our method is quick, experimentally easy to set up, allows for real-time 
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monitoring of solute flux, and accounts for substrate rigidity.  
 
2.2 Introduction 
The endothelial cell (EC) layer of the vasculature forms a semi-permeable barrier 
separating flowing blood from the underlying tissues and controls the passage of 
solutes, fluids and immune cells. Increased permeability is a hallmark of endothelial 
cell dysfunction and can result in pathologies including edema and chronic 
inflammation. Moreover, it is considered a critical first step in atherogenesis (Sima et 
al., 2009). Vascular permeability is regulated in part by the dynamic opening and 
closing of inter-endothelial cell junctions (Dejana et al., 2008). In addition to cell-cell 
interactions, cell-ECM interactions play a crucial role in the regulation of permeability 
(Mehta and Malik, 2006). Data to-date suggests that the nature of the endothelial 
basement membrane and the connection between cells and their matrix can alter 
permeability (Qiao et al., 1995). However, there are no platforms available to 
systematically alter both the chemical and mechanical nature of the ECM to evaluate 
their effects on endothelial monolayer permeability.  
 
 Currently, in vitro endothelial permeability is most commonly quantified by 
either measuring the movement of an inert fluorescently-labeled molecule across an 
EC monolayer or by performing transendothelial electrical resistance measurements. 
In the former technique, cell monolayers are grown on microporous polycarbonate 
filter inserts that are suspended in a culture chamber. The passage of an inert 
molecule, such as FITC-conjugated albumin or dextran, is detected by sampling media 
from the apical and basal chambers and measured using spectrophotometry. While 
straightforward, these studies are not without certain disadvantages—since the flux of 
small molecules across the membrane is due to simple diffusion into a relatively large 
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reservoir, experiments last several hours and coincidentally, data may not be indicative 
of real-time barrier function. Moreover, the technique requires that cells be seeded on 
filters that do not necessarily mimic the chemical or mechanical properties of the in 
vivo environment. 
 
In transendothelial electrical resistance (TEER) measurements, electrodes are 
placed in the apical and basal compartments and the electrical resistance across the 
endothelial monolayer is monitored. TEER studies are highly sensitive and are able to 
resolve real-time fluctuations in permeability but are more difficult to perform 
experimentally. Similar to the fluorescent dye measurements described above, cells 
are also plated directly onto polycarbonate membranes in TEER experiments. These 
membranes can be coated with ECM proteins such as collagen or fibronectin; 
however, the Young’s modulus of polycarbonate is several orders of magnitude higher 
than that of native blood vessels. Therefore, neither system can accurately recapitulate 
the in vivo mechanical environment.  
 
A growing body of data suggests that substrate mechanics play an important 
role in governing cell function important in the vasculature, including capillary 
morphogenesis (Califano and Reinhart-King, 2008; Kniazeva and Putnam, 2009), 
neutrophil transendothelial migration (Rabodzey et al., 2008), and vascular smooth 
muscle cell migration (Isenberg et al., 2009). Yet, no research has been done to 
elucidate the role of substrate mechanics on endothelial permeability. Here, we 
describe a method to measure the permeability of ECs cultured on flexible hydrogel 
substrates which mimic the Young’s modulus of native vessels. These same substrates, 
which were first described by Pelham and Wang (Pelham and Wang, 1997), have been 
widely adopted in the cell and tissue engineering community because they are easy to 
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fabricate, can be conjugated with a variety of ECM proteins, and are mechanically 
tunable. Our approach holds several key advantages over conventional permeability 
studies—it has simple experimental setup, is able to measure cumulative flux of 
solutes in real-time, permits real-time observation of cells, and most importantly, 
accounts for physiological substrate rigidity.  
 
2.3 Materials and methods 
Polyacrylamide gel synthesis 
Polyacrylamide (PA) gels were synthesized as previously described (Califano and 
Reinhart-King, 2008). Briefly, glass coverslips were activated by sequential washing 
in 0.1 N NaOH, 3-aminopropyltrimethoxysilane, and 0.5% glutaraldehyde (Sigma-
Aldrich, St. Louis, MO). 5 and 30 kiloPascal (kPa) gels were polymerized onto 
activated coverslips using ratios of 7.5% to 0.175% or 12% to 0.28% acrylamide to 
bis-acrylamide, respectively. Gel surfaces were derivatized with 0.1 mg/ml rat tail 
collagen type I (BD Biosciences, San Jose, CA).  
 
Cell culture and drug treatments 
Bovine aortic endothelial cells (BAECs) were maintained in Medium 199 (Invitrogen, 
Carlsbad, CA) supplemented with 10% FetalClone III (HyClone, Logan, UT), and 1% 
each of penicillin-streptomycin (Invitrogen), MEM amino acids (Invitrogen), and 
MEM vitamins (Mediatech, Manassas, VA). Simvastatin, BW245C, Y27632, and 40 
kDa fluorescein isothiocyanate (FITC)-conjugated dextran (Sigma-Aldrich) were 
diluted to final concentrations of 100 µM, 1 µM, 10 µM, and 10 µM, respectively. 
Bovine thrombin (Calbiochem, San Diego, CA), recombinant bovine tumor necrosis 
factor α (TNF-α, R&D Systems, Minneapolis, MN), and recombinant human vascular 
endothelial growth factor (VEGF 165, R&D Systems) were used at 4 U/ml, 100 ng/ml, 
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and 50 ng/ml, respectively. 
 
Immunofluorescent staining 
BAECs that were two days post-confluence were fixed with 3.7% formaldehyde 
(VWR International, West Chester, PA) and permeabilized with 1% Triton (VWR). 
Gels were sequentially incubated with a 1:50 dilution of goat polyclonal VE-cadherin 
primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and a 1:200 dilution of 
Alexa Fluor 568 donkey anti-goat secondary antibody (Invitrogen). Phase and 
fluorescent images were captured on a Zeiss Axio Observer.Z1m microscope equipped 
with a Hamamatsu ORCA-ER camera. 
 
Measurement of endothelial permeability 
BAECs were seeded onto PA gels at a density of 10,000 cells/cm2 and allowed to 
grow to confluence. Two days post-confluence, BAECs were refreshed with 
Leibovitz’s L15 media containing 10% FetalClone III (HyClone) and 1% penicillin-
streptomycin (Invitrogen) and maintained at 37° C. To evaluate endothelial 
permeability, a 10 µM solution of 40 kDa FITC-conjugated dextran was added to the 
cells for 5 minutes. For simvastatin, BW245C, and Y27632 experiments, BAECs were 
pretreated with each agonist for 30 minutes. For barrier-disruptive agonists, BAECs 
were pretreated with TNF-α for 4 hours or were treated simultaneously with bovine 
thrombin in FITC-conjugated dextran for up to 15 minutes. Human VEGF was also 
administered simultaneously in FITC-conjugated dextran for 5 minutes. Confocal z-
slice images (512 x 512 pixels) were obtained on a Leica TCS SP2 system equipped 
with a 40x dipping lens. 
 
 To quantify endothelial permeability, fluorescence intensities of the images 
 47 
were measured using ImageJ software (v. 1.42q, National Institutes of Health, 
Bethesda, MD). A 50 x 400 pixel rectangular box was drawn directly above the cell 
layer and the average pixel intensity, which represents the intensity of 10 µM FITC-
dextran, was recorded. A second box of width 400 pixels was then drawn directly 
below the cell layer and encompassed the entire height of the PA gel, which 
represented the average pixel intensity of FITC-dextran that had permeated through 
the cell monolayer into the gel. Dextran accumulation was calculated as the average 
pixel intensity within the gel divided by the average pixel intensity above the gel. 
Relative permeability values were then calculated as the dextran accumulation values 
of cell-seeded gels normalized to cell-free gels. 
 
Statistical analysis 
All data are reported as mean ± SEM. Student’s t-test or two-way ANOVA with 
Bonferroni post-tests were performed for statistical analysis using GraphPad Prism (v. 
5.00, GraphPad Software, Inc., La Jolla, CA). p values < 0.05 were considered 
significant. 
 
2.4 Results 
2.4.1 Bovine aortic endothelial cells maintain their ability to grow into confluent 
monolayers on polyacrylamide gels 
To study the permeability of endothelial monolayers on substrates of physiological 
stiffness, BAECs were seeded on compliant gels and allowed to grow to confluence 
and form a cobblestone monolayer. Gels were fabricated with a Young’s modulus of 5 
kPa which corresponds to the elasticity of the arterial media as determined previously 
by AFM (Engler et al., 2004). As shown in Figure 2.1, on both glass and 
polyacrylamide, BAECs preserve their classic cobblestone morphology (Fig. 2.1A and 
 48 
B) and form cell-cell junctions (Fig. 2.1C and D). While these data indicate that the 
monolayer morphology is similar, it is not clear if permeability remains the same.  
 
2.4.2 Confocal microscopy can be used to measure FITC-dextran accumulation 
across an endothelial monolayer into a polyacrylamide gel 
To quantify the permeability of BAEC monolayers on gels, we tracked the movement 
of fluorescently-labeled dextran through the monolayer into the gel. Cells were seeded 
on the gel as described in Figure 2.1, and FITC-dextran is added to the culture. 
Because the polyacrylamide substrates are porous, inert molecules that pass through 
the endothelial barrier enter the gel (Fig. 2.2A and C). Analogous to sampling media 
from apical and basal chambers as is performed in traditional flux assays, permeability 
is measured based on the fluorescent intensities above and within the gels.  
 
Using confocal microscopy, an image of the z-plane of the cell-seeded gel 
immersed in FITC-dextran is taken (Fig. 2.2B). As a control, images in the absence of 
cells are acquired (Fig. 2.2D). The pixel intensity within the cell-seeded gel is 
decreased compared to the intensity within the cell-free gel at the same time interval 
(Fig. 2.2D), indicating as expected that the presence of the endothelial monolayer (in 
Fig. 2.2B) acts as a barrier to the diffusion of fluorescently-labeled dextran into the 
gel. To compare the differences in pixel intensities and therefore permeability 
characteristics of the cell-free and confluent cell conditions, the cumulative dextran 
accumulation was measured. The dye accumulation was defined as the fluorescent 
intensity within the gel divided by the intensity measured above the gel.  
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Figure 2.1. Micrographs of bovine aortic endothelial cell monolayers seeded on glass 
(A, C) and on 5 kPa polyacrylamide gels (B, D). (A) and (B): phase images, (C) and 
(D): immunofluorescent staining of VE-cadherin. Scale bars, 50 µm. 
 
  
 50 
 
 
 
Figure 2.2. Schematic diagram of real-time permeability measurements. Cartoon 
schematic of dextran accumulation in gels with confluent cells (A) and without cells 
(C). (B) and (D) are representative confocal cross-sections of (A) and (C) after 
immersion in 40 kDa FITC-dextran (10 µM) for 5 minutes, depicting the method used 
to measure permeability. Dashed white lines represent the top and bottom edges of the 
gel. Permeability values of BAEC-seeded gels were calculated as the pixel intensity 
within the gel divided by the pixel intensity above the gel normalized to that 
calculated in cell-free gels. Scale bar, 20 µm. 
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To validate this metric, we characterized the time-dependent accumulation of dextran 
into gels with and without cells over 15 minutes (Fig. 2.3). As expected, cell-free gels 
had the highest cumulative dextran accumulation over the entire 15 minutes (Fig. 2.3A 
and B). Without any cell barrier impeding the diffusion of solutes, dextran 
accumulation plateaus at approximately t=5 min, likely due to the saturation of 
dextran within the gel. For this reason, all later experiments were performed with 5 
minutes of dextran addition. The gels seeded with cells maintained the lowest dextran 
accumulation at each time point, with values of about 65% lower than that of cell-free 
gels (Fig. 2.3B), indicating that confluent BAECs are able to form a functional semi-
permeable barrier restricting the movement of solutes into the hydrogel. To validate 
our method as a measure of permeability, we also tested BAEC monolayers treated 
with 4 U/ml thrombin, a vasoactive agent known to increase vascular permeability 
(Coughlin, 2000). When the endothelial barrier was perturbed by thrombin, dextran 
accumulation was higher at each time point throughout the length of the experiment 
compared to the untreated cell-seeded gels.  
 
Because the porosity and diffusive properties of PA gels change relative to its 
stiffness and degree of cross-linking, the dextran accumulation within a gel of a given 
stiffness was normalized against the accumulation in a cell-free gel (Fig. 2.3C and 
2.4). This normalized permeability metric was used to gauge the relative 
permeabilities of BAEC monolayers on gels in treated vs. non-treated conditions. As 
seen in Figure 2.3C, thrombin significantly increased endothelial barrier permeability 
as early as t=4 min. When comparing the permeability of thrombin-treated cells at t=1 
and t=15 min, we found a 2.2-fold increase in accumulation, whereas in the untreated 
conditions, there was only a 1.5-fold increase in dye accumulation after 15 minutes. 
Additionally, our data shows that thrombin increased endothelial permeability by 
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about 73% (Fig. 2.4A) at t=5 min.  
 
In addition to thrombin, we treated cells on gels with an array of known 
barrier-altering agonists (Fig. 2.4A). Human VEGF and recombinant bovine TNF-α, 
two other well-known barrier-disruptive agonists, significantly increased the relative 
permeability of BAEC monolayers on gels by a factor of 1.4 and 1.6, respectively. We 
also tested the effect of three barrier-enhancing agonists, simvastatin (van Nieuw 
Amerongen et al., 2000), Y27632 (Uehata et al., 1997), and BW245C (Murata et al., 
2008). In all three cases, permeability as measured in our assay decreased. These data 
further validate our approach as a tractable method for measuring permeability.  
 
2.4.3 Increased polyacrylamide gel stiffness induces endothelial permeability 
Our lab and others (Califano and Reinhart-King, 2008; Guo et al., 2006; Ryan et al., 
2001) have shown that cell-cell adhesion is increased on more compliant matrices 
which may lead to enhanced barrier function and decreased permeability. We tested 
this hypothesis by measuring the permeability of cells cultured on gels of two different 
stiffnesses—one that mimics the elasticity of the arterial media (5 kPa) and another 
that is much stiffer than physiologically relevant but less stiff than polycarbonate (30 
kPa). Permeability of cells cultured on 30 kPa gels was significantly higher than on 5 
kPa gels (Fig. 2.4B), similar to the increase in permeability when cells on 5 kPa gels 
were treated with thrombin. This suggests that substrate stiffness alone may enhance 
endothelial permeability similarly to drug challenges. Surprisingly, the addition of 
thrombin to the 30 kPa condition did not significantly increase measured permeability, 
indicating that a diffusion limit may exist in our system where we are unable to  
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Figure 2.3. Endothelial permeability measurements. (A) Representative time lapse z-
sections of 5 kPa polyacrylamide gels with or without bovine aortic endothelial cell 
monolayers, as well as cells treated with thrombin (4 U/ml), immersed in FITC-
dextran. Dashed lines represent top and bottom edges of the gel. Scale bar, 20 µm. (B) 
Quantification of FITC-dextran accumulation with respect to time in 5 kPa gels 
without cells (solid circles), with cells treated with thrombin (open triangles), and with 
untreated cells (solid squares). Data are means ± SEM. (C) Permeability values of 
thrombin-treated (open triangles) or untreated (solid squares) cells cultured on 5 kPa 
substrates normalized by the dextran accumulation values of the gels without cells. 
Data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t test) 
comparing thrombin-treated to untreated groups.  
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Figure 2.4. (A) Effects of known barrier-disruptive (VEGF, TNF-α, thrombin) and 
barrier-enhancing (simvastatin, Y27632, BW245C) agonists on the permeability of 
BAEC monolayers on 5 kPa polyacrylamide gels. Permeability values are normalized 
to that of untreated cells. Data are means ± SEM. **P < 0.01, ***P < 0.001 
(Dunnett’s test) compared to untreated cells. (B) Effect of substrate stiffness (5 vs. 30 
kPa) on cells treated with or without thrombin. *P < 0.05, ***P < 0.001 (Tukey’s 
test). 
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capture the full response of cells to thrombin treatment. Overall, these data underscore 
the importance of substrate mechanics and cell-matrix adhesions in modulating 
permeability which has been long overlooked in traditional permeability studies. 
 
2.5 Discussion 
Here we describe a novel method to measure the permeability of endothelial 
monolayers grown on soft polyacrylamide substrates that more closely mimic the 
stiffness of the physiological microenvironment. Using confocal microscopy, we can 
track the accumulation of FITC-labeled 40 kDa dextran through cell monolayers into 
their underlying PA gel to determine endothelial permeability. Validation of our 
methods was completed by measuring permeability after treatments with known 
barrier-disruptive and barrier-enhancing agonists. Lastly, we found that when 
increasing polyacrylamide stiffness from 5 to 30 kPa, endothelial permeability was 
enhanced, indicating that current methods to measure endothelial permeability using 
stiff polycarbonate substrates may not accurately capture what is occurring in vivo. 
 
An interesting result elucidated in our studies was that the permeability of our 
monolayers was significantly lower that what others have found. Specifically, when 
compared to values reported by previous membrane-passage studies with BAECs, our 
relative permeability values were noticeably lower. In a study performed by Chang et 
al., BAECs stimulated with VEGF for 2 hours yielded a 4-fold increase in 
permeability, whereas Stockton et al. found 2.5-fold increases in permeability after 30 
minutes of VEGF or TNF-α treatment (Chang et al., 2000; Stockton et al., 2004). In 
comparison, we found only a 1.4 and 1.6-fold increase in permeability after treatment 
with VEGF and TNF-α, respectively (Fig. 2.4A). Although timing of the drug 
treatments are different, we suspect matrix mechanics to play a role in mediating cell 
 56 
susceptibility to drug treatment. Indeed, previous data suggests that cells are more 
sensitive to agonists on stiffer substrates (Brown et al., 2010; Paszek et al., 2005).  
 
We also treated BAEC monolayers with several barrier-enhancing agonists, 
including Y27632, a specific inhibitor of Rho-associated kinase (ROCK) which is 
involved in cell contraction (Satoh et al., 2011; Zhou et al., 2011). In response, BAEC 
monolayers on 5 kPa gels exhibited a significant decrease in dextran flux (Fig. 4A), 
suggesting that by inhibiting cell contractility and therefore cell-matrix adhesions, 
cells maintain stronger cell-cell junctions and a less permeable barrier. In addition to 
Y27632, we tested the effect of simvastatin, a widely prescribed drug that inhibits 
cholesterol production (Armitage et al., 2010; Ijioma and Robinson, 2011), on 
endothelial permeability. Although treatment with simvastatin of cells on PA gels 
reduced endothelial permeability slightly, the result is not statistically different from 
baseline (P=0.12). Simvastatin has been found to protect endothelial monolayers from 
barrier-disruptive agonists (Chen et al., 2008; van Nieuw Amerongen et al., 2000), but 
it may not have a significant barrier-enhancing effect on non-disrupted cells. It is 
possible that when cultured on 5 kPa substrates that match the stiffness of healthy 
bovine arteries (Engler et al., 2004), BAECs may not respond to simvastatin treatment. 
However, based on our data showing increased permeability due to increased substrate 
stiffness (Fig. 2.4B), we suspect that on stiff substrates that more closely mimic a 
disease state, simvastatin may have a positive effect by lowering endothelial 
permeability. Together, these data underscore the importance of substrate mechanics 
and cell-matrix adhesions in modulating permeability which has been long overlooked 
in traditional permeability studies.  
 
It is important to note that the porosity of polyacrylamide changes with its 
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stiffness. Although we did not directly measure the porosity of our substrates in this 
study, Williams and colleagues have done extensive work characterizing the void 
fraction of PA gels with respect to FITC-labeled dextran size (Williams et al., 1998). 
Intuitively, high percentage PA gels, which are stiffer, are less porous than their lower 
percentage and softer counterparts. Additionally, the fractional volume of gel available 
to solutes such as dextran decreases with increasing solute size. In our studies, we 
found that cells cultured on 30 kPa gels did not exhibit increased permeability when 
treated with thrombin (Fig. 2.4B). Because thrombin has been shown extensively to 
elicit increased endothelial permeability on even stiffer substrates, e.g. polycarbonate, 
we believe that our findings are not the result of endothelial cells being unresponsive 
to thrombin when cultured on 30 kPa gels but rather a limitation in the gel fraction 
available for FITC-dextran accumulation. 
 
In summary, we have developed and validated a novel technique for measuring 
endothelial permeability while taking into consideration the effects of substrate 
mechanics. Our method is quick, easy to set up, and allows for real-time monitoring of 
cumulative solute flux. Moreover, it more closely mimics the in vivo environment 
which our data indicates has an important effect on permeability. 
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CHAPTER 3 
 
AGE-RELATED INTIMAL STIFFENING ENHANCES ENDOTHELIAL 
PERMEABILITY AND LEUKOCYTE TRANSMIGRATION 
 
Published in Science Translational Medicine (Huynh et al., 2011). 
 
3.1 Abstract 
Age is the most significant risk factor for atherosclerosis; however, the link between 
age and atherosclerosis is poorly understood. During both aging and atherosclerosis 
progression, the blood vessel wall stiffens owing to alterations in the extracellular 
matrix. Using in vitro and ex vivo models of vessel-wall stiffness and aging, we show 
that stiffening of extracellular matrix within the intima promotes endothelial cell 
permeability—a hallmark of atherogenesis. When cultured on hydrogels fabricated to 
match the elasticity of young and aging intima, endothelial monolayers exhibit 
increased permeability and disrupted cell-cell junctions on stiffer matrices. In parallel 
experiments, we showed a corresponding increase in cell-cell junction width with age 
in ex vivo aortas from young (10 weeks) and old (21 to 25 months) healthy mice. To 
investigate the mechanism by which matrix stiffening alters monolayer integrity, we 
found that cell contractility increases with increased matrix stiffness, mechanically 
destabilizing cell-cell junctions. This increase in endothelial permeability results in 
increased leukocyte extravasation, which is a critical step in atherosclerotic plaque 
formation. Mild inhibition of Rho-dependent cell contractility using Y-27632, an 
inhibitor of Rho-associated kinase, or siRNA restored monolayer integrity in vitro and 
in vivo. Our results suggest that extracellular matrix stiffening alone, which occurs 
during aging, can lead to endothelial monolayer disruption and atherosclerosis 
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pathogenesis. Because previous therapeutics designed to decrease vascular stiffness 
have been met with limited success, our findings could be the basis for the design of 
therapeutics that target the Rho-dependent cellular contractile response to matrix 
stiffening, rather than stiffness itself, to more effectively prevent atherosclerosis 
progression. 
 
3.2 Introduction 
Vascular stiffening accompanies a variety of cardiovascular pathologies including 
hypertension (Laurent and Boutouyrie, 2007) and atherosclerosis (Fernandes et al., 
2008). The blood vessel wall also stiffens with age (McEniery et al., 2005). During 
aging, vessel stiffness increases owing to changes in the micro-scale architecture of 
the extracellular matrix (ECM) within the vessel wall, namely the increases in elastin 
fragmentation, collagen deposition, and matrix protein cross-linking (Greenwald, 
2007; Zieman et al., 2005). This matrix stiffening decreases arterial distensibility and 
capacitance and can increase mechanical strain on the heart. Macroscopic 
measurements of arterial stiffness are often used for clinical diagnosis and can 
independently predict cardiovascular events, such as coronary heart disease and stroke 
(Mattace-Raso et al., 2006) and mortality in elderly patients (Sutton-Tyrrell et al., 
2005). Although vascular stiffening occurs ubiquitously with age and is a predictor of 
cardiovascular risk, little is known about how vessel stiffness affects endothelial cells 
within blood vessels where arteriosclerosis initiates.   
 
 Recent evidence suggests that matrix stiffness affects cell behaviors (Discher 
et al., 2005), including cell spreading and adhesion (Pelham and Wang, 1997), 
migration (Zaman et al., 2006), and differentiation (Engler et al., 2006). It has been 
shown to alter vascular smooth muscle cell phenotype (Peyton and Putnam, 2005) and 
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promote intimal hyperplasia (Lemarié et al., 2010). Our own data suggest that changes 
in matrix stiffness can alter cell-cell contact (Reinhart-King et al., 2008). Because cell-
cell contact is directly linked to monolayer integrity and permeability, we 
hypothesized that increased matrix stiffness with age may disrupt barrier function of 
the endothelium. Increased endothelial permeability to lipoproteins and immune cells 
is considered the initiating step of atherosclerosis pathogenesis, and the accumulation 
of debris in the intima results in the formation of atherosclerotic plaques (Lee et al., 
2005; Lusis, 2000; Ross, 1999). Notably, decreasing permeability decreases plaque 
formation (Rozenberg et al., 2010; Sun et al., 2011). Endothelial permeability is 
controlled in part by the dynamic opening and closing of endothelial cell-cell junctions 
(Dejana et al., 2008), which are directly affected by interactions between endothelial 
cells and the ECM (Mehta and Malik, 2006). Although the intima stiffens during aging 
and atherosclerosis progression, and endothelial permeability occurs with age and is 
regarded as one of the first steps in atherogenesis, the relationship between age-related 
blood-vessel stiffening, endothelial cell function, and monolayer integrity has not been 
investigated in depth. 
 
 Because endothelial permeability is known as an early event in atherogenesis, 
we explored the effects of age-related matrix stiffness on endothelial barrier function 
using both in vitro and ex vivo models of intimal stiffening and aging. We found that 
stiffening of the matrix increased monolayer permeability. This increase in 
permeability was the result of upregulated cell contractility, which mechanically 
disrupted cell-cell junctions and promoted leukocyte transmigration—a critical step in 
atherosclerotic plaque formation. Pharmacological inhibition of cell contractility in 
vivo in mice reversed the effects of matrix stiffness on endothelial permeability by 
restoring tight cell-cell junctions, and also decreased leukocyte transmigration. These 
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findings suggest that matrix stiffening alone, which occurs during the natural aging 
process, can directly cause endothelial cell permeability and atherosclerosis 
progression. 
 
3.3 Materials and methods 
Cell culture and gel synthesis   
Bovine aortic endothelial cells (BAECs) were maintained in Medium 199 (Invitrogen, 
Carlsbad, CA) with 10% FetalClone III (HyClone, Logan, UT) and supplements. 
Human umbilical vein endothelial cells (HUVECs) were maintained in Medium 200 
(Invitrogen) supplemented with low serum growth supplement (Invitrogen) and 5% 
fetal bovine serum (Invitrogen). Polyacrylamide gels were prepared as described 
previously (Califano and Reinhart-King, 2008) and coated with 0.1 mg/ml rat tail 
collagen type I (BD Biosciences, San Jose, CA). 2.5, 5, and 10 kPa gels were made 
according to the ratios 5%:0.1%, 7.5%:0.175%, and 7.5%:0.35% 
acrylamide:bisacrylamide, respectively. All in vitro experiments were performed two 
days after the cells reached confluence.  
 
Measurement of in vitro and in vivo endothelial permeability   
For in vitro studies, a 10-µM solution of 40-kDa FITC-conjugated dextran (Sigma-
Aldrich, St. Louis, MO) was added to BAECs for 5 min. For barrier-altering agonist 
experiments, BAECs were either pretreated with 1 µM BW245C (Sigma-Aldrich) for 
30 min or 100 ng/ml recombinant bovine TNF-α (R&D Systems, Minneapolis, MN) 
for 4 h which was then washed out before being immersed in FITC-dextran for 5 min. 
For human VEGF (50 ng/ml, R&D Systems) or bovine thrombin (4 U/ml, 
Calbiochem, San Diego, CA) experiments, drugs were administered simultaneously in 
FITC-conjugated dextran for 5 min. For Y-27632 experiments, BAECs were 
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pretreated with 10 µM Y-27632 (Sigma-Aldrich) for 30 min which was then washed 
out before the addition of FITC-dextran. Confocal z-slices were obtained on a Leica 
TCS SP2 equipped with a 40× dipping lens. To calculate relative permeability, 
fluorescent intensities of images were measured using ImageJ software (NIH, v. 
1.42q). Dextran accumulation was determined on the basis of the fluorescent intensity 
within the gel normalized by the fluorescent intensity above the BAEC monolayer. 
This value was then normalized against dextran accumulation values determined for 
polyacrylamide gels without cells. 
 
 All animal protocols were approved by the Cornell University Institutional 
Animal Care and Use Committee. For in vivo studies, endothelial permeability was 
measured with an Evans blue assay (Sun et al., 2011). Briefly, C57BL/6 mice were 
anesthetized on isoflurane, and 0.1 mg/kg Y-27632 in PBS or PBS only was 
administered retro-orbitally and allowed to circulate for 1 h while mice were allowed 
to wake. Mice were again anesthetized and 20 mg/kg Evans blue dye (Sigma-Aldrich) 
was administered retro-orbitally and allowed to circulate for 1 h while mice were 
allowed to wake. After re-anesthetizing, 10 ml PBS was perfused through the left 
ventricle, and the thoracic aorta was excised and cleaned of connective tissue. After 
drying at 80° C for 18 h, aortas were weighed. Aortas were then immersed in 150 µl 
formamide (Sigma-Aldrich) and incubated at 60° C for 24 h to extract Evans blue. 
Absorbance was read at 620 nm. The amount of dye was determined using standard 
curves and normalized to aorta dry weight.  
 
Histology and atomic force microscopy indentation of mouse thoracic aortas 
C57BL/6 mice were deeply anesthetized on isoflurane and euthanized. In the Y-27632 
group, 0.1 mg/kg Y-27632 in PBS was administered retro-orbitally and allowed to 
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circulate for 1 h while mice were allowed to wake. The thoracic aorta was dissected, 
and individual sections were cut from the aorta, opened longitudinally, and gently 
scraped 10–15 times with a cotton-tipped applicator to remove the endothelium. To 
verify de-endothelialization, scraped and unscraped samples were fixed in 3.7% 
buffered formaldehyde and submitted to the university’s histology service for routine 
hematoxylin & eosin (H&E) staining. Images were acquired using an Olympus AX70 
microscope with a 40× objective and an Optronics Microfire digital camera. Scraped 
samples purposed for indentation testing were bonded to a glass substrate using 
Loctite gel adhesive (Henkel Corporation, Dusseldorf, Germany) and kept submerged 
in PBS. 
 
The stiffness of the subendothelium was measured by atomic force microscopy 
indentation. A PicoPlus II scanning probe microscope (Agilent Technologies, Santa 
Clara, CA) and Au-coated SiN 0.12 N/µm cantilevers modified with 10-µm diameter 
polystyrene beads (Novascan, Ames, IA) were used. Photodetector sensitivity was 
calibrated using force curves taken in PBS on a rigid substrate. The cantilever spring 
constant kc (Equation 3.1) was calibrated using Hutter’s thermal noise method with 
corrections for cantilever tilt and optically-measured deflection (Butt and Jaschke, 
1995; Hutter, 2005; Hutter and Bechhoefer, 1993).  
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where kB is Boltzmann’s constant, T is temperature, <z2> is mean squared 
displacement of the primary bending mode, R is tip radius, L is cantilever length, and 
α is cantilever tilt angle. The calibrated spring constants were in the range of 0.10–
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0.11 N/m. Indentation speed was 1 µm/s.  All testing was done at room temperature 
and within 12 hours of animal death. In this window, we believe mechanical properties 
were maintained, as previous data suggests that when arteries are tested within several 
hours of isolation at temperatures between 22 and 37°C, there are no detectable 
changes in their mechanical properties (Gow et al., 1983; Schaar et al., 2002). Others 
have used similar transport procedures for testing of the medial layer and do not report 
any issue with cell viability (Engler et al., 2004; Engler et al., 2007). Additionally, 
other groups have used artery segments stored for longer times (>24 h) without loss of 
the smooth muscle cell contractile phenotype (Basha et al., 2006; Smolock et al., 
2009).  
 
 Indentation force curves were analyzed using the Hertz model, which is 
appropriate for a spherical indenter and described in Equation 3.2: 
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where F is the applied force, E is the Young’s modulus, R is the tip indenter radius, δ 
is indent depth, and ν is Poisson’s ratio. Incompressibility was assumed (ν = 0.5). The 
contact point was chosen visually and the point-by-point modulus Epp calculated by 
fitting each data point individually to Epp (Equation 3.3): 
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The shape of the Epp vs. δ plot is sensitive to errors in the contact point (Crick and Yin, 
2007). If an erroneous contact point was indicated, the contact point was corrected. 
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Curves in which the indenter failed to deform the tissue were discarded. A single 
indentation modulus value E was calculated for each indentation site by interpolating 
the Epp vs. δ plot with a 5-point moving average, calculating an average Epp vs. δ 
curve, and averaging Epp over all δ. The resulting E is a measure of the indented site’s 
overall stiffness.  
 
Stiffness measurements of polyacrylamide gels 
Steel balls (Abbott Ball Co., West Hartford, CT) with known density, ρ = 7,200 kg/m3, 
and radius, R = 0.32 mm, were placed on polyacrylamide gels embedded with 0.5-µm 
fluorescent beads. A microscope was used to measure the indentation depth, δ, of the 
steel balls as they were magnetically removed from the gels as has previously been 
described (Lo et al., 2000; Reinhart-King et al., 2003). Gel stiffnesses were then 
calculated using the Hertz model for spherical contact. Recorded values of δ were 
inputted into the equation for Young’s modulus, E (Equation 3.4): 
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where the Poisson’s ratio, ν, for polyacrylamide was assumed to be 0.3 (Li et al., 
1993), and )( capVVgF −= ρ , where g is 9.81 m/s2, V is the volume of the steel ball, 
and Vcap is the indentation volume.  
 
In vitro and ex vivo VE-cadherin junctional gap width quantification 
BAECs on polyacrylamide gels were immunostained with goat polyclonal VE-
cadherin primary antibody (C-19, Santa Cruz Biotechnology, Santa Cruz, CA) and 
Alexa Fluor 568 donkey anti-goat secondary antibody (Invitrogen). Actin was stained 
with FITC-conjugated phalloidin (Sigma-Aldrich) and nuclei with DAPI (Sigma-
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Aldrich). Images were captured on a Zeiss Axio Observer.Z1m microscope with a 
Hamamatsu ORCA-ER camera.  
 
 C57BL/6 mice were anesthetized on isoflurane, and 0.1 mg/kg Y-27632 in 
PBS or PBS only was administered retro-orbitally and allowed to circulate for 1 h 
while mice were allowed to wake. The mice were then deeply anesthetized with 
isoflurane, overdosed on pentobarbital and intracardially perfused with cold 1% 
paraformaldehyde at an average flow rate of 10 ml/min, which matches the blood flow 
in mice to minimize artifacts from perfusion (Huo et al., 2008). Aortas were extracted 
and post-fixed in 1% paraformaldehyde for 1 h. Sections of the descending thoracic 
aorta approximately 1 mm long were stained with a biotinylated monoclonal antibody 
against mouse CD144 (13-1221, eBioscience, San Diego, CA). Secondary label was 
Texas Red streptavidin (SA-5006, Vector Laboratories, Burlingame, CA or S872, 
Invitrogen). Aortic sections were opened longitudinally and covered with a coverslip. 
Endothelial cells were imaged using a locally-built two-photon-excited fluorescence 
microscope using 830-nm excitation (MIRA-HP, Coherent, Santa Clara, CA) with a 
63×, 1.2 NA objective (Zeiss, Germany) and 645/65-nm emission filter (Chroma 
Technology, Bellows Falls, VT).  
 
 Junctional gap width measurements were analyzed using ImageJ and a custom-
written MATLAB algorithm. Briefly, using fluorescent images of VE-cadherin, a line 
was drawn perpendicular to the widest gap per junction, and the intensity profiles were 
recorded using ImageJ. A two-Gaussian curve was then fit to the intensity profiles in 
MATLAB. Gap widths were defined as the width of the two-Gaussian fit 20% above 
background pixel intensity.  
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Measurement of RhoA activity  
BAEC intracellular RhoA activity was quantified using a RhoA G-LISA kit 
(Cytoskeleton, Denver, CO) according to the manufacturer’s protocol.  
 
Traction force microscopy   
BAECs plated on polyacrylamide gels embedded with 0.5-µm diameter fluorescent 
beads (Invitrogen) were allowed to adhere for 24 h. Isolated cells were imaged in 
phase, and the fluorescent bead field beneath the cell was imaged immediately after. A 
second fluorescent image of the bead field was taken after cells were removed with 
0.05% trypsin/EDTA (Invitrogen). Bead displacements were used to compute cellular 
traction vectors, T, and total magnitudes of force, | F |, using the LIBTRC analysis 
library developed by M. Dembo (Dembo and Wang, 1999). | F | (Equation 3.5) is the 
sum of the traction field magnitudes over the entire cell area, 
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where )],(),,([),( yxTyxTyxT yx=  is the continuous field of cellular traction vectors 
defined at spatial position (x, y) over the entire cell area (Reinhart-King et al., 2005). 
 
RNA interference 
BAECs at 90% confluency on tissue culture plastic were transfected with 10 nM non-
targeting (control) siRNA or siRNA targeting ROCK1 using 2 µg/ml Lipofectamine 
2000 (Invitrogen). The non-targeting sequence was 5’-
AAUCAUCAAGUCUUAACCCGUACUC-3’. The sequence targeting ROCK1 was 
5’-CAGAAGUGCAGAACGUCAAACAUAA-3’. Both the control siRNA and the 
siRNA targeting ROCK1 (accession number NM_001191227.1) were synthesized by 
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Invitrogen. ROCK1 interference was quantified by Western blot densitometry. Primary 
antibodies against ROCK1 and GAPDH were purchased from Santa Cruz 
Biotechnology and Millipore, Billerica, MA, respectively.  
 
Neutrophil transmigration and rolling adhesion 
All human subject protocols have been approved by the Institutional Review Board for 
Human Participants at Cornell University. Fresh peripheral human blood was collected 
into vacutainer tubes containing heparin and allowed to equilibrate at room 
temperature. Blood was layered over 1-Step Polymorphs (Accurate Chemical, 
Westbury, NY) and separated by centrifugation. The neutrophil layer was collected, 
washed, and resuspended in flow buffer (0.5% human serum albumin (Sigma-
Aldrich), 10 mM HEPES and 2 mM CaCO3 in Hank’s Balanced Salt Solution). 
HUVEC monolayers pre-treated with 0.1 ng/ml recombinant human TNF-α (R&D 
Systems) for 6 h were either untreated or treated with 10 µM Y-27632 for 1 h. 
Neutrophils (50,000 cells/cm2) were then allowed to adhere for 5 min. Gels were 
gently washed twice with flow buffer to remove unattached neutrophils. HUVEC VE-
cadherin was stained as described previously, and neutrophils were stained with a 
FITC-conjugated antibody against human CD45 (Invitrogen). Images were taken on a 
Zeiss LSM710 confocal microscope with a 25× objective. Transmigrated neutrophils 
were defined as CD45-positive cells with at least 50% of its cell body located beneath 
the endothelial layer.  
 
Flow chamber assembly and leukocyte rolling experiments  
Human umbilical vein endothelial cells (HUVECs) on polyacrylamide gels were 
stimulated with 0.1 ng/ml recombinant human TNF-α (R&D Systems) for 6 h. A 
rectangular parallel-plate flow chamber (GylcoTech, Gaithersburg, MD) with a gasket 
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of size 0.254 cm × 1 cm × 6 cm (h × w × l) was carefully assembled over 
polyacrylamide gels and held together by vacuum. The flow chamber assembly was 
secured onto the stage of an Olympus IX81 microscope equipped with a Hitachi CCD 
camera (KP-M1AN) connected to a DVD recorder (DVO-1000MD, Sony 
Electronics). A syringe pump (KDS 230, IITC Life Science, Woodland Hills, CA) was 
used to control the flow rate of the cell suspension. Neutrophils at a concentration of 
150,000 cells/ml flow buffer (0.5% human serum albumin (HSA, Sigma-Aldrich), 10 
mM HEPES and 2 mM CaCO3 in Hank’s Balanced Salt Solution were perfused at a 
wall shear stress of 2 dyn/cm2 for a total period of 7 min. “Rolling” cells were defined 
as those observed to translate in the direction of flow with an average velocity less 
than 50% of the calculated hydrodynamic free stream velocity. During flow, 79–96 
random fields of view (640 × 480 pixels, 1.52 pixel/µm) were recorded using a 20× 
objective (NA 0.4, Olympus).  
 
Flow cytometry  
HUVECs on gels were treated with 0.1 ng/ml TNF-α for 6 h. Gels were rinsed with 
PBS and inverted onto accutase (MP Biomedicals, Solon, OH). Cells were dislodged 
by pipetting and pelleted by centrifugation. After blocking with 1% goat serum, cells 
were incubated with primary antibodies against ICAM-1, VCAM-1, or E-selectin, or 
mouse IgG1 isotype control (R&D Systems). Secondary label was Alexa Fluor 488 
anti-mouse antibody (Invitrogen). Labeled cells were resuspended and analyzed using 
an Accuri C6 flow cytometer. 
 
Statistical analysis 
All analyses were completed using JMP 8 (SAS Institute, Cary, NC) or GraphPad 
Prism 5 (GraphPad Software, Inc., La Jolla, CA). Data in Fig. 3.1B, Fig. 3.2C, Fig. 
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3.5A, Fig. 3.5B, and Fig. 3.8 were analyzed by parametric one-way ANOVA with 
post-hoc Tukey’s test to compare untreated conditions. Two-way ANOVA with post-
hoc Tukey’s test was then used to compare Y-27632 or ROCK1-targeted siRNA data 
to its respective control. Data in Fig. 3.3D and 3.4 were analyzed by non-parametric 
Kruskal-Wallis ANOVA with post-hoc Dunn’s test. Data in Fig. 3.5C were analyzed 
using Student’s t test. All data are means ± SEM. P values < 0.05 were considered 
significant. 
 
3.4 Results 
3.4.1 Increased matrix stiffness promotes endothelial monolayer permeability 
by destabilizing cell-cell junctions   
We first investigated the effect of substrate stiffness on the barrier function of 
endothelial monolayers. To mimic the stiffness of young and aged intima, synthetic 
hydrogel substrates (Reinhart-King, 2008) were fabricated that approximated and 
exceeded the Young’s Modulus of 2.7 ± 1.1 kPa reported previously for the 
subendothelial matrix in bovine carotid arteries (Peloquin et al., 2011). Bovine aortic 
endothelial cells (BAECs) were seeded on polyacrylamide substrates of 2.5, 5 and 10 
kPa. Endothelium permeability was measured on the basis of 40 kDa FITC-dextran 
movement across the monolayer (Fig. 3.1A). 40 kDa FITC-dextran was chosen as its 
hydrodynamic radius (~4.8 nm) approximates that of albumin (~3.6 nm) (Armstrong 
et al., 2004), a model protein commonly used in permeability studies (Cooper et al., 
1987) and whose permeation through the endothelium is associated with 
cardiovascular pathologies such as diabetes (Mogensen, 1984) and atherosclerosis 
(Pedrinelli et al., 1998). Importantly, endothelial monolayer permeability increased as 
a function of matrix stiffness (Fig. 3.1B), which suggests that matrix stiffness alone,  
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Figure 3.1. Matrix stiffness increases endothelial permeability. (A) A cartoon shows 
FITC-dextran permeation through an endothelial monolayer into a polyacrylamide gel. 
On the right is a representative confocal cross-section of dextran capture in a 2.5-kPa 
polyacrylamide gel, depicting the method used to measure permeability. Dashed lines 
represent the top and bottom edges of the gel. Permeability values of cell (BAEC)-
seeded gels were calculated as the pixel intensity within the gel divided by the pixel 
intensity above the gel normalized to that calculated in cell-free gels. Scale bar, 20 
µm. (B) Relative permeability of BAECs cultured on substrates matching (2.5 kPa) 
and exceeding (5 and 10 kPa) the stiffness of bovine arterial intima with (n = 8 gels, 
three independent experiments) or without (n = 16–20 gels, ten independent 
experiments) Y-27632 treatment. Data are means ± SEM. *P < 0.05, **P < 0.01, ***P 
< 0.001 (Tukey’s test) compared to respective untreated conditions unless otherwise 
indicated by brackets. 
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Figure 3.2. Matrix stiffness increases cell-cell junction width. (A) Fluorescent images 
showing VE-cadherin (red), actin (green), and nuclei (blue) of confluent BAECs on 
gels. Performed in collaboration with Joe Califano. (B) VE-cadherin junctional gap-
width measurement. Left: VE-cadherin immunostaining of bovine aortic endothelial 
cells cultured on polyacrylamide gels. Scale bar, 5 µm. Right: Blue dots represent the 
pixel intensity profile of the yellow line drawn in the left image, whereas the red line 
represents a two-Gaussian fit calculated using a MATLAB program written by Mike 
King. The junction width was considered as the width of the fitted curve at 20% above 
baseline intensity, as indicated by the dashed green line. (C) VE-cadherin junction-
width measurements of BAECs on gels with or without 30 min Y-27632 treatment (n 
= 60 junction measurements, two independent experiments). Scale bar, 10 µm. Data 
are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 (Tukey’s test) compared to 
respective untreated conditions unless otherwise indicated by brackets.  
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without any externally added agonists, promotes increased endothelial monolayer 
permeability. 
 
 To investigate the mechanism by which substrate stiffness contributes to 
changes in permeability, we probed the integrity of the cell-cell junctions within the 
endothelial monolayer by fluorescently imaging vascular endothelial (VE)-cadherin 
(Fig. 3.2A), a cell-cell adhesion molecule that mediates endothelium stabilization 
(Dejana et al., 2009). Using methods similar to those that have been described 
previously (van Nieuw Amerongen et al., 2007) where lines were drawn 
perpendicularly to cell junctions to determine pixel intensities (Fig. 3.2B), we 
measured the separation width of intercellular junctions on polymers of varying 
stiffnesses (2.5 to 10 kPa). These measurements indicated that the distance between 
cells increased as a function of matrix stiffness (Fig. 3.2C). Together, these data 
suggest that increased matrix stiffness disrupts the formation of cell-cell junctions in 
vitro, which increases endothelial permeability. 
 
3.4.2 Age-related intimal stiffening disrupts endothelial cell-cell junction 
integrity 
Because blood vessel stiffness increases with age, and because our in vitro data 
indicated that increased matrix stiffness destabilizes cell-cell junctions (Fig. 3.2), we 
investigated the effects of aging and vessel stiffness on endothelial permeability and 
cell-cell junction integrity in a mouse model. We first characterized the intimal 
stiffness of de-endothelialized thoracic aortas of young (10 to 11 weeks) and old (21 to 
25 months) mice using atomic force microscopy (AFM) (Fig. 3.3). To remove 
endothelial cells from the subendothelium, a cotton applicator was used to gently 
scrape away endothelial cells (Peloquin et al., 2011). H&E staining was used to ensure 
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endothelial cells were removed without damaging the structural integrity of the 
subendothelium (Fig. 3.3A). Representative Hertzian fit to AFM force-indentation 
data and point-by-point modulus vs. indentation depth plots are shown in Figs. 3.3B 
and C, respectively. Using this data, we found a significant increase in indentation 
modulus of the subendothelium with age (Fig. 3.3D). This measured modulus for 
young mice (31.9 ± 4.5 kPa, mean ± SEM) was higher than the value found for 18 to 
30 month-old bovine carotid intima (2.7 ± 0.6 kPa, mean ± SEM) (Peloquin et al., 
2011), presumably owing to the close proximity of the first internal elastic lamina 
relative to the lumen of the mouse vessel, which prevents the intima from deforming 
fully under indentation. The bovine carotid intima is more similar to the human carotid 
intima in its structure. Despite the difference between the moduli found for bovine and 
mouse intima, our data confirm that there is a relative increase in ECM stiffness in 
blood vessels with age.  
 
Using a different set of young (10 weeks) and old (16 to 24 months) mice than 
those used in the stiffness measurements (Fig. 3.3D), we visualized endothelial cell-
cell junctions within intact aortas based on VE-cadherin localization using two-photon 
microscopy (Fig. 3.4A). Intercellular distance, measured as the widest VE-cadherin 
separation width between two adjacent cells, was greater in aged, stiffer aortas than in 
younger, more compliant vessels (Fig. 3.4B), similar to the effects measured in vitro 
on stiffer matrices (Fig. 3.2C). In another set of young (9 weeks) and old (19 to 22 
months) mice, we measured the permeability of thoracic aortas with an Evans blue dye 
assay and found that Evans blue deposition within the vessel wall increased with age 
(Fig. 3.4C). These data suggest that, with age, the intima stiffens, causing endothelial 
cell-cell junctions to separate and increase permeability. 
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Figure 3.3. Histology and AFM indentation of mouse thoracic aorta. (A) H&E 
staining of native and de-endothelialized aorta to show successful removal of ECs 
with minimal damage to underlying ECM. The section is perpendicular to the flow 
axis. Gentle scraping with a cotton applicator removes the ECs (asterisks) from the 
artery lumen, exposing the subendothelium for indentation. Scale bar, 50 µm. (B) 
Example least-squares fit of the Hertz model to AFM data, which shows the validity of 
the Hertz contact equation as a method to calculate the indentation modulus of mouse 
aortas. Insert: Residual error of the fit. (C) Example point-by-point modulus Epp 
versus indentation depth plot obtained by individually fitting each data point in (B). 
After the initial noisy region (δ < 0.03), the Epp is approximately 50 kPa. (D) AFM 
indentation measurements of thoracic aorta of untreated young (10 to 11 weeks, n = 61 
indent sites, 3 aortas) and old (20 to 25 months, n = 55 indent sites, 5 aortas) mice, as 
well as Y-27632-treated old (20 months, n = 76 indent sites, 4 aortas) mice. Data are 
means ± SEM. ***P < 0.001 (Dunn’s test). Experiments performed in collaboration 
with John Peloquin. 
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Figure 3.4. Aging increases endothelial intercellular junction separation in mice. (B) 
Permeability measurements of thoracic aorta of untreated young (9 weeks, n = 4 
aortas) and old (19 to 22 months, n = 6 aortas) mice, as well as Y-27632-treated old 
(20 months, n = 4 aortas) mice. Data are means ± SEM. *P < 0.05, **P < 0.01 
(Dunn’s test). (C) Two-photon microscopy of VE-cadherin immunofluorescent 
staining in endothelial cells of intact, untreated young (10 week) and old (16 month) 
thoracic mouse aortas, as well as Y-27632-treated old (24 month) thoracic aortas. 
Scale bar, 10 µm. (D) VE-cadherin junction width measurements of thoracic aortic 
endothelial cells from untreated young (10 weeks, n = 240 width measurements, 4 
aortas) and old (16 to 24 months, n = 390 width measurements, 7 aortas) mice, as well 
as Y-27632-treated old (21 to 24 months, n = 156 width measurements, 3 aortas) mice. 
Data are means ± SEM. **P < 0.01, ***P < 0.001 (Dunn’s test). Experiments 
performed in collaboration with Nozomi Nishimura and Chris Schaffer. 
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3.4.3 Endothelial permeability and cell-cell junctions are regulated by cell 
contractility 
Previous work suggests that endothelial permeability is regulated in part by the 
cellular cytoskeleton and cell contractility (Birukova et al., 2009). The Rho signaling 
pathway is a well-established mediator of the sustained contraction of the cytoskeleton 
(Mehta and Malik, 2006; Shyy, 2002). Evidence in other cell types suggests that 
matrix stiffness induces changes in Rho activation (Huang and Ingber, 2005; Paszek et 
al., 2005). When activated, Rho and its downstream effector Rho-associated kinase 
(ROCK) stimulate cell contractility by modulating actomyosin contraction and cell-
matrix adhesion. To explore the intracellular mechanisms by which the mechanical 
properties of the matrix affect monolayer permeability, we hypothesized that stiffer 
substrates induce Rho activation, leading to increased cell contractility, the physical 
separation of cell-cell junctions, and increased permeability. Using a commercially 
available Rho detection kit, we found increased Rho activity in endothelial cells on 10 
kPa substrates compared to those on 2.5 kPa substrates (Fig. 3.5A). To ensure that 
Rho activation was not altered by the concentration of acrylamide within the hydrogel 
substrates but rather by stiffness, we made two formulations of gels with different 
acrylamide concentrations that were both approximately 2.5 kPa in stiffness (Fig. 
3.5B). Rho activity was unchanged (Fig. 3.5C), suggesting that polymer composition 
does not activate Rho independently of stiffness. To determine if increased Rho 
activity resulted in increased cell contractility, we used traction force microscopy to 
quantify the forces exerted by endothelial cells as a function of matrix stiffness. 
Endothelial cells exerted stronger traction forces on 10 kPa substrates than on 2.5 kPa 
substrates (Fig. 3.6A), and the total magnitude of cellular force increased as a function 
of matrix stiffness (Fig. 3.6B).   
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Figure 3.5. Rho activity increases due to matrix stiffening. (A) Rho activity of BAECs 
cultured on polyacrylamide gels of different stiffness (three independent experiments, 
each performed in duplicate). Data are means ± SEM. **P < 0.01, ***P < 0.001 
(Tukey’s test). (B and C) Gels made from different acrylamide concentrations that are 
similar in stiffness elicit similar levels of Rho activation. Experiments performed in 
collaboration with Joe Califano. (B) Stiffness measurements of polyacrylamide gels of 
varying percentages of acrylamide and bisacrylamide. Data are means ± SEM (n = 7–8 
measurements, 2 gels per group). ***P < 0.001, ns (not significant), (Tukey’s test) 
compared to 5% acrylamide/0.1% bisacrylamide. (C) Intracellular Rho activity of 
bovine aortic endothelial cells seeded on polyacrylamide gels of similar stiffness. Data 
for the 5% acrylamide/0.1% bisacrylamide is re-plotted from the 2.5 kPa group of (A). 
Data are means ± SEM (n = 3 independent experiments, each performed in duplicate). 
ns, not significant (Student’s t test). 
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Figure 3.6. Matrix stiffness increases cell contractility, and inhibition of cell 
contractility restores barrier integrity. (A) Representative traction force distribution 
maps and phase images of BAECs on gels. Scale bars, 50 µm. (B) Traction force 
microscopy measurements of cell contractility with (n = 9–12 cells) or without (n = 
19–34 cells) Y-27632 treatment. Data are means ± SEM. *P < 0.05, **P < 0.01, ***P 
< 0.001 (Tukey’s test) compared to respective untreated conditions, unless otherwise 
indicated by brackets. 
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 To further investigate the role of the Rho pathway in regulating increased 
cellular contractility and monolayer permeability in response to matrix stiffness, we 
inhibited ROCK, a downstream target of Rho, using the pharmacological inhibitor Y-
27632. When ROCK was inhibited by exposing cells to Y-27632 for 30 min, cellular 
force decreased to a similar level across all matrices (Fig. 3.6B). Furthermore, 
endothelial permeability on 5 and 10 kPa substrates decreased to levels found on 2.5 
kPa substrates (Fig. 3.1B). Similarly, endothelial permeability decreased with addition 
of siRNA targeting ROCK1 (Fig. 3.7). In our mouse model, Y-27632 treatment of old 
(20 months) mice also decreased the permeability of the thoracic aorta endothelium to 
Evans blue dye compared to untreated old mice (Fig. 3.4C). These data indicate that 
age-related stiffness-induced permeability is mediated by increased contractility and 
that decreasing contractility restores monolayer integrity.  
 
Measurements of cell-cell junction separation width in Y-27632-treated cells 
demonstrated that decreasing ROCK activity decreases the average cell-cell separation 
distance to about 2 µm (Fig. 3.2C). Likewise, cell-cell separation decreased 
significantly in Y-27632-treated old (21 to 24 months) mice compared to untreated old 
mice (Fig. 3.4C). Y-27632 treatment did not change intimal stiffness (Fig. 3.3D), 
suggesting that Y-27632 acts intracellularly to inhibit contractility, but does not cause 
local matrix rearrangement and stiffness changes. Taken together, these data indicate 
that increased endothelial monolayer permeability in response to matrix stiffness is the 
result of greater cell contractility, which destabilizes and widens intercellular 
junctions.  Importantly, our data suggest that the adverse effect of age-related matrix 
stiffening can be reversed in vivo by inhibiting Rho pathway–mediated cell 
contractility. 
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Figure 3.7. RNAi of ROCK1 decreases stiffness-induced endothelial permeability. (A) 
(Top) Western blot analysis and (bottom) densitometry quantification of RNAi of 
ROCK1 (n = 2). (B) Relative permeability of BAECs cultured on gels of varying 
stiffnesses with (n = 13–15 gels) or without (n = 13 gels) siRNA knockdown of 
ROCK1. Data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 (Tukey’s test) 
compared to respective control siRNA, unless otherwise indicated by brackets. 
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3.4.4 Increased matrix stiffness promotes leukocyte transmigration   
Because VE-cadherin rearrangement and monolayer permeability are known to 
regulate leukocyte transmigration into the vessel wall (Alcaide et al., 2008; Turowski 
et al., 2008), we asked whether stiffer substrates and the subsequent widening of 
junctions promote increased transmigration of leukocytes, a crucial step in the 
formation of atherosclerotic plaques. Primary human leukocytes were seeded on top of 
TNF-α–stimulated endothelial cells that were first seeded on polyacrylamide matrices. 
Leukocytes that had transmigrated were defined as those in which at least 50% of their 
cell body appeared beneath the endothelial monolayer (Fig. 3.8A). Notably, the 
number of transmigrated leukocytes increased as a function of matrix stiffness (Fig. 
3.8B), and Y-27632 treatment of endothelial monolayers decreased transmigration 
(Fig. 3.8B), which suggests that decreased cell-cell separation inhibits leukocyte 
transmigration. Of the cells that transmigrated, between 87 and 98% migrated through 
the monolayer at cell-cell junctions (Fig. 3.8C), indicating that paracellular 
transmigration dominated over transcellular transmigration. 
 
 To determine if increased transmigration may also be due to differential 
expression of endothelial inflammatory molecules associated with leukocyte adhesion 
and transmigration, we also investigated the number of captured leukocytes under 
shear (to mimic blood flow) and the relative expression levels of intercellular adhesion 
molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-
selectin—three endothelial cell inflammatory markers responsible for mediating 
leukocyte adhesion to the endothelium. Our data revealed no differences in leukocyte 
attachment to TNF-α–stimulated endothelial cells as a function of matrix stiffness 
(Fig. 3.9). Additionally, the expression levels of ICAM-1 (Fig. 3.10A), VCAM-1 (Fig. 
3.10B), and E-selectin (Fig. 3.10C) in TNF-α-treated endothelial cells did not change  
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Figure 3.8. Matrix stiffness enhances leukocyte transmigration. (A) Representative 
fluorescent images of leukocytes (green) transmigrating through an endothelial 
monolayer (VE-cadherin, red). Experiments performed in collaboration with Kuldeep 
Rana and Mike King. Images were taken at focal planes above the monolayer (+2.5 
µm), at the monolayer (0 µm), and below the monolayer (–2.5 µm). Arrows indicate 
transmigrated cells. Scale bar, 20 µm. (B) Histogram showing the effect of matrix 
stiffness on the number of transmigrated leukocytes. Endothelial cells were either 
untreated (n = 19 fields of view, three independent experiments) or pre-treated with Y-
27632 (n = 17–18 fields of view). Data are means ± SEM. **P < 0.01 (Tukey’s test) 
compared to respective untreated condition, unless otherwise indicated by brackets. 
(C) Percentage of leukocytes that transmigrated through intercellular junctions. 
Numbers above bars indicate the nominal values. Data are means ± SEM.  
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Figure 3.9. Leukocytes captured on HUVEC monolayers on polyacrylamide gels 
under flow. (A) Representative micrographs of captured leukocytes. Yellow 
arrowheads indicate attached leukocytes. Leukocytes were rolled for 7 min in a 
parallel-plate flow chamber at 2 dyn/cm2. Scale bar, 50 µm. (B) The effect of substrate 
stiffness on the number of captured leukocytes. Data are means ± SEM (n = 79 to 96 
fields of view per stiffness). ns, not significant (Tukey’s test). Experiments performed 
in collaboration with Kuldeep Rana and Mike King. 
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Figure 3.10. Flow cytometry analysis of HUVEC expression of (A) ICAM-1, (B) 
VCAM-1, and (C) E-selectin on gels after a 6-h treatment with TNF-α. Shaded green 
curves represent overlapping mouse IgG isotype controls (msIgG) for each of the three 
matrices. Three independent experiments were performed. No statistically significant 
differences (Tukey’s test) were found between the three stiffnesses for all three 
adhesion molecules. Experiments performed in collaboration with Christine 
Montague. 
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as a function of matrix stiffness. Mouse IgG isotype controls were used to ensure non- 
specific binding of antibodies was not different between stiffnesses. These results 
suggest that the increase in transmigration on stiffer matrices is probably not from a 
differential upregulation of inflammatory molecules associated with leukocyte 
attachment, but rather an increase in cell-cell junction separation, which promotes 
transmigration. 
 
3.5 Discussion 
Vessel stiffening accompanies the progression of both aging and atherosclerosis and is 
used to predict risk of cardiovascular diseases (Mattace-Raso et al., 2006; Sutton-
Tyrrell et al., 2005); yet, the relationship between age-related changes in ECM 
mechanical properties that result in blood vessel stiffening and endothelial cell 
permeability is relatively unknown. In the present study, we demonstrate that 
increased vessel stiffness promotes disruption of endothelial barrier integrity, a 
hallmark of atherogenesis. Moreover, we demonstrate that by inhibiting endothelial 
cellular contractility via the Rho/ROCK pathway, we can prevent increased 
permeability with age. Because increased permeability of the endothelium permits 
cholesterol uptake in the vessel wall (Lusis, 2000), these results demonstrate one 
possible therapeutic approach to preventing cholesterol accumulation within the vessel 
wall is to inhibit increased endothelial cell contractility. 
 
Recently, others have also shown that endothelial cell contractile pathways 
modulate permeability (Krishnan et al., 2011) and leukocyte transmigration (Stroka 
and Aranda-Espinoza, 2011; Sun et al., 2011). Krishnan et al. (Krishnan et al., 2011) 
showed that human umbilical vein endothelial cells (HUVECs) generated strong 
traction forces on stiff substrates (11 kPa) and formed intercellular gaps when treated 
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with permeability-inducing agent thrombin; whereas cells on more compliant 
substrates (1.2 kPa) were less contractile and did not form gaps in response to 
thrombin. Sun et al. (Sun et al., 2011) showed that non-muscle myosin light-chain 
kinase deficiency, which reduces endothelial contractility, attenuates endothelial 
permeability and monocyte transmigration in an atherosclerotic mouse model. 
Importantly, we reversed the negative effects of matrix stiffening in both our mouse 
and in in vitro models by pharmacologically inhibiting Rho-dependent cell contraction 
(Fig. 3.6B). In addition to matrix stiffening, ROCK inhibition has also been shown to 
inhibit the negative effects of barrier-disruptive agonists that increase cell contractility, 
such as thrombin (van Nieuw Amerongen et al., 2000) and TNF-α (Nwariaku et al., 
2003). These data collectively indicate that inhibiting increased endothelial cell 
contractility may inhibit the progression of atherosclerosis.  
 
 To assess cardiovascular risk clinically, non-invasive techniques, such as pulse 
wave velocity tests, have been implemented to indirectly measure patient arterial 
stiffness (Blacher et al., 1999). Because stiffness is known to correlate with the risk of 
cardiovascular disease, there is now substantial interest in the discovery or design of 
therapeutics that target vessel stiffening to prevent and treat cardiovascular disease. 
Thus far, several drugs have been identified, including angiotensin-converting enzyme 
inhibitors and calcium channel blockers (Oliver and Webb, 2003). However, their 
mechanisms of action within the endothelium are poorly understood and often 
confounded owing to their actions on other aspects of the cardiovascular system, like 
blood pressure and heart rate (Hope and Hughes, 2007). More recently, alagebrium, a 
drug that disrupts advanced glycation end-product (AGE) crosslinks that stiffen vessel 
walls, has shown mild success in treating patients with chronic (Willemsen et al., 
2010) or diastolic heart failure (Little et al., 2005) and improving endothelial flow-
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mediated dilation in patients with systolic hypertension (Zieman et al., 2007). 
Therefore, there is evidence clinically that decreasing vessel stiffness can improve 
patient health.  
 
Here, we present another approach to mitigate the deleterious effects of vessel 
stiffening on cardiovascular health. Rather than exclusively targeting vessel stiffness, 
we propose that also targeting the endothelial cells’ response to vessel stiffening may 
also prevent or slow atherogenesis. In some cases, directly targeting the stiffening 
within vessel walls is beneficial because decreasing vessel stiffness decreases the load 
on the heart and can decrease risk of heart failure. However, in the case of 
atherosclerosis, a therapy which also targets the endothelium may have certain 
advantages over using “de-stiffening” agents alone. ROCK inhibitors, as were used 
here, work quickly through intracellular signaling pathways rather than on the matrix 
within the vessel wall, which may require long-term treatment before significant 
changes occur. Because decreasing cellular contractility decreases permeability, which 
is one of the first steps in atherogenesis, ROCK-inhibition therapy may be more 
suitable for patients who are at-risk or in the very early stages of arteriosclerosis. In 
those patients with advanced atherosclerosis, inhibiting endothelial contractility may 
slow the growth of atherosclerotic lesions by preventing additional cholesterol uptake 
and inflammatory cell transmigration, but may not directly reduce the size of lesions 
that are already present. Therefore, ROCK-inhibition therapy will likely be best used 
as a preventative treatment for atherosclerosis and should be used in conjunction with 
additional therapies for the treatment of other cardiovascular complications, like heart 
failure, that are also due in part to vessel stiffening. 
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 Currently, fasudil is the only ROCK inhibitor approved for clinical use (Dong 
et al., 2010). Originally used to treat cerebral vasospasm, fasudil has shown promise in 
treating a variety of cardiovascular diseases, including pulmonary hypertension 
(Fukumoto et al., 2005), atherosclerosis (Nohria et al., 2006), and aortic stiffness 
(Noma et al., 2007). Ongoing phase II clinical trials using fasudil are being performed 
to understand the relationship between Rho-dependent cell signaling and carotid 
atherosclerosis (ClinicalTrials.gov Identifier: NCT00670202). There is also some 
evidence that statins, which include the widely marketed Crestor and Lipitor brands, 
decrease Rho/ROCK activity through pleiotropic effects (Dong et al., 2010). As such, 
statins, in addition to their known ability to lower cholesterol levels in the blood, may 
also be effective in lowering cholesterol accumulation in the vessel wall by restoring 
barrier integrity. Overall, our data indicate that pharmacological ROCK inhibition may 
prevent atherosclerosis progression by preventing increased endothelial monolayer 
permeability and leukocyte transmigration due to vessel wall stiffening.  
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CHAPTER 4 
 
SUBSTRATE STIFFNESS PROMOTES CIRCULAR DORSAL RUFFLE 
FORMATION IN VASCULAR SMOOTH MUSCLE CELLS 
 
4.1 Abstract 
As atherosclerosis progresses, vascular smooth muscle cells (VSMCs) invade from the 
medial layer into the intimal layer and proliferate, contributing to atherosclerotic 
plaque formation. This migration is stimulated in part by platelet-derived growth 
factor (PDGF) released by endothelial cells or inflammatory cells trapped in the vessel 
microenvironment, and also vessel stiffening, which occurs with age and 
atherosclerosis progression.  PDGF induces the formation of circular dorsal ruffles 
(CDRs), actin-based structured associated with increased cell motility. Here we show 
that mechanical changes in vessel stiffness enhance the formation of CDRs in VSMCs 
in response to PDGF stimulation. Our data indicate that matrix stiffness increases 
cellular contractility, and that intracellular pre-stress is necessary for robust CDR 
formation. When treated with agonists that promote contractility, cells increase CDR 
formation, whereas agonists that inhibit contractility lead to decreased CDR 
formation. Substrate stiffness promotes CDR formation in response to PDGF by 
upregulating myosin light chain kinase and Src activity. Together, these data indicate 
that vessel stiffening accompanying atherogenesis may exacerbate VSMC migration 
by increasing CDR formation in response to PDGF. 
 
4.2 Introduction 
During atherosclerosis, the vessel wall stiffens due to excess extracellular matrix 
(ECM) deposition, matrix crosslinking, and elastin fragmentation (Greenwald, 2007; 
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Zieman et al., 2007). Vascular smooth muscle cells, which populate the arterial media, 
convert from a quiescent phenotype to exhibit abnormal ECM deposition and 
migration into the vascular intima (Beamish et al., 2010; Davis-Dusenbery et al., 
2011), leading to fibrotic plaque formation and blood vessel occlusion (Lusis, 2000; 
Ross, 1999). Matrix stiffness has been shown to modulate VSMC migration (Isenberg 
et al., 2009; Peyton and Putnam, 2005) and proliferation (Brown et al., 2010; 
McDaniel et al., 2007), cell behaviors that occur with atherosclerotic plaque 
generation. Thus, arterial stiffening may be a contributing factor for the progression of 
atherosclerosis.  
 
Circular dorsal ruffles (CDRs) are thought to play a role in directed vascular 
smooth muscle migration (Gu et al., 2011; Huang et al., 2011). They are transient 
actin-based structures that form in VSMCs in response to platelet-derived growth 
factor (PDGF) signaling. In this signaling cascade, PDGF binding to its receptor 
results in Src phosphorylation. Phosphorylated Src activates and modulates a number 
of downstream effector proteins, including F-actin, the Arp2/3 complex, WAVE-1/2, 
neuronal Wiskott-Aldrich Syndrome protein (N-WASP), and cortactin (Buccione et 
al., 2004). These proteins act in concert to reorganize actin into CDRs.  
 
It is believed that wide-scale actin cytoskeletal rearrangements induced by 
CDRs allows cells to become polarized and motile (Ballestrem et al., 1998). Quiescent 
contractile VSMCs typically exhibit robust stress fibers and cell-matrix attachments 
that inhibit cell migration. When stimulated with growth factors, actin stress fibers 
dissasemble and are reorganized into CDRs, leaving a meshwork of disassembled 
cortical actin to be used for lamellipodia extension and cell migration (Krueger et al., 
2003). Additionally, CDRs may also function to release matrix metalloproteinases 
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(MMPs) which degrade ECM and facilitate cell invasion (Suetsugu et al., 2003).  
 
Because CDRs are actin-based structures and because actin is known to form 
more robust stress fibers in response to matrix stiffness (Assoian and Klein, 2008; 
Discher et al., 2005), we hypothesized that CDR formation in VSMCs is modulated by 
the mechanical properties of the extracellular microenvironment. Our data indicate 
that substrate stiffness enhances F-actin organization and cellular contractility priming 
cells for robust PDGF-stimulated CDR formation. Given that CDRs are thought to 
enable migration, these data indicate that blood vessel stiffening during atherosclerosis 
may promote intimal hyperplasia and VSMC migration by inducing CDR formation. 
 
4.3 Materials and methods 
Cell culture and gel synthesis   
A7R5 rat aortic VSMCs obtained from American Type Culture Collection (ATCC) 
were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, 
Carlsbad, CA) with 10% fetal bovine serum (Invitrogen) and 1% 
penicillin/streptavidin (Invitrogen). Polyacrylamide (PA) gels were prepared as 
described previously (Huynh et al., 2011) and coated with 0.002 to 0.2 μg/ml rat tail 
collagen type I (BD Biosciences, San Jose, CA). Briefly, 22 × 22 mm or 48 × 65 
coverslips (VWR International, Radnor, PA) were activated by subsequent washing in 
0.1 N sodium hydroxide (VWR), 3-aminopropyltrimethoxysilane (VWR), and 0.5% 
glutaraldehyde (Sigma-Aldrich, St. Louis, MO). 1, 2.5, 5, 10, and 30 kiloPascal (kPa) 
gels were polymerized onto activated coverslips according to the ratios 3%:0.1%, 
5%:0.1%, 7.5%:0.175%, 7.5%:0.35%, and 12%:0.28% acrylamide:bisacrylamide 
(Bio-Rad, Hercules, CA), respectively. Cells were seeded onto PA gels and incubated 
overnight prior to further experimentation. 
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Drug treatments 
To induce circular dorsal ruffle formation, VSMCs were treated with 10 ng/ml 
platelet-derived growth factor (PDGF-BB) (R&D Systems, Minneapolis, MN) for 5 
min. In some studies, cells were pre-treated with 10 nM calyculin A for 5 min (Sigma-
Aldrich) or 10 μM ML-7 for 30 min (Sigma-Aldrich).  
 
Immunofluorescent staining 
A7R5s on PA gels were fixed in 3.7% formaldehyde and subsequently washed in 1% 
Triton X-100 (Mallinckrodt Baker, Phillipsburg, NJ), 0.2% Tween (Mallinckrodt 
Baker), and blocked with 3% bovine serum albumin (Sigma-Aldrich). Cells were then 
immunostained with a 1:200 dilution of mouse monoclonal α-actinin (Sigma-Aldrich) 
or rabbit polyclonal cortactin primary antibody (Santa Cruz Biotechnology, Santa 
Cruz, CA). Secondary antibodies were Alexa Fluor 568 donkey anti-mouse or anti-
rabbit (Invitrogen). Actin was stained with Alexa Fluor 488 phalloidin (Invitrogen) 
and nuclei with 4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich). Images were 
captured on a Zeiss Axio Observer.Z1m microscope with a Hamamatsu ORCA-ER 
camera.  
 
Western blotting 
A7R5 cells cultured on 48 × 65 mm PA gels were lysed with a modified radio-
immunoprecipitation assay (RIPA) buffer (150 mM sodium chloride, 50 mM Tris-
hydrochloride, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1% Nonidet 
P40, 25 mM sodium fluoride, 1 mM sodium orthovanadate, 1:500 dilution of protease 
inhibitor cocktail (Sigma-Aldrich)). Cell lysate was cleared by centrifugation at 
14,000 x g and the supernatant was separated by sodium dodecyl sulfate 
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polyacrylamide gel electrophoresis (SDS-PAGE). After protein transfer onto 
nitrocellulose, blots were probed using antibodies against phosphorylated myosin light 
chain at threonine-18 and serine-19 (pMLC) (Cell Signaling Technology, Beverly, 
MA), total myosin light chain (MLC) (Cell Signaling Technology), phosphorylated 
Src at Tyr-416 (pSrc) (Cell Signaling Technology), and total Src (Cell Signaling 
Technology). Anti-rabbit horseradish peroxidase (HRP) conjugated secondary 
antibodies were obtained from Cell Signaling Technology or Santa Cruz 
Biotechnology. After incubation in SuperSignal West Pico Chemiluminescent 
Substrate (Thermo Scientific, Rockford, IL), blots were exposed and imaged using a 
FujiFilm ImageQuant LAS-4000. Protein densitometry was performed using ImageJ 
software (v. 1.46, National Institutes of Health, Bethesda, MD) 
 
Traction force microscopy   
A7R5 cells were cultured overnight on PA gels embedded with 0.5 µm diameter 
fluorescent beads (Invitrogen). Individual cells and the stressed fluorescent bead field 
beneath the cell were imaged. After cell removal with 0.05% trypsin-EDTA 
(Invitrogen), a second fluorescent image of the unstressed bead field was imaged. 
Bead displacements were calculated from the stressed and unstressed images and used 
to compute cellular traction vectors and total magnitudes of force using the LIBTRC 
analysis library developed by Dr. Micah Dembo (Department of Biomedical 
Engineering, Boston University).  
 
Statistical analysis 
Statistical analyses were performed using JMP 8 (SAS Institute, Cary, NC), GraphPad 
Prism 5 (GraphPad Software, Inc.), or Excel 2010 (Microsoft, Corporation, Redmond, 
WA). Parametric one-way or two-way ANOVA with post-hoc Tukey’s honest 
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significance test were performed where appropriate. P values < 0.05 were considered 
statistically significant.  
 
Data in Fig. 4.2B were fit to a dose-response curve (Poch and Pancheva, 1995) 
described by Equation 4.1: 
 
𝑌 = 𝐸𝑚𝑖𝑛 + 𝐸𝑚𝑎𝑥 −𝐸𝑚𝑖𝑛 1+( 𝑥
𝐸𝐷50
)ℎ  ,  (Eqn. 4.1) 
 
where Y is the response (in this case, percentage of cells exhibiting CDRs), Emin is the 
minimum response, Emax is the maximum response, x is the dose (in this case, 
stiffness), h is the Hill slope, and ED50 is the effective dose that elicits a half-maximal 
response. The values for Emin, Emax, and h were constrained to stay constant between 
collagen densities. 
 
4.4 Results 
4.4.1 Matrix stiffening, but not increased collagen density, promotes circular 
dorsal ruffle formation 
Using PA gels varying in stiffness from 1 to 30 kPa, we first observed A7R5 VSMCs 
actin organization with respect to substrate stiffness. With increasing stiffness, 
VSMCs better organize their actin cytoskeleton into F-actin-rich stress fibers (Fig. 
4.1A). On soft substrates (1 and 2.5 kPa gels) cells spread less and do not form many 
stress fibers; however, on stiff substrates (10 kPa and above) cells are much more 
well-spread and exhibit robust stress fibers that extend the length of the cell. After 
inducing circular dorsal ruffle formation in VSMCs with PDGF, cells were fixed and 
stained for actin and either α-actinin or cortactin, markers of CDRs. The colocalization 
of these proteins was used to determine the formation of CDRs with respect to matrix 
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stiffness (Fig. 4.1B). Quantification of the percentage of cells that exhibit CDRs 
reveals that a larger percentage of cells cultured on stiff substrates formed CDRs 
compared to those cultured on more compliant substrates (Fig. 4.2A).  
 
Because protein density has been shown to alter VSMC spreading and 
migration speeds (Peyton and Putnam, 2005), we tested whether the collagen density 
conjugated to the PA gels affects the formation of CDRs. We modeled the percentage 
of cells that exhibit CDRs versus substrate stiffness and collagen density as a 
pharmacokinetic dose-response curve, where stiffness was modeled as the dose. 
Compared to 0.002 or 0.02 mg/ml collagen, 0.2 mg/ml collagen shifted the stiffness-
response curve to the left, indicating that on substrates conjugated with 0.2 mg/ml 
collagen, a higher percentage of cells formed CDRs on lower stiffness (Fig. 4.2B). 
Additionally, the effective dose that elicits a half-maximal response, or ED50, 
decreased from ~12 kPa on 0.002 and 0.02 mg/ml collagen-conjugated gels to ~7 kPa 
on 0.2 mg/ml collagen-conjugated gels. Together, our data suggest that stiffer 
substrates and higher collagen densities promote the formation of CDRs. 
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Figure 4.1. Representative images of A7R5 vascular smooth muscle cell actin 
organization cultured on polyacrylamide gels varying in stiffness from 1 to 30 kPa 
without (A) and with (B) 5 min PDGF-induced circular dorsal ruffles. Cells were 
stained for F-actin using Alexa Fluor 488 phalloidin. Scale bar, 50 μm. 
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Figure 4.2. Increased substrate stiffness, but not collagen density, promotes circular 
dorsal ruffle formation. (A) The percentage of cells exhibiting PDGF-induced CDR 
formation on polyacrylamide gels derivatized with 0.2 mg/ml rat tail type I collagen (n 
= 6 independent experiments). Data are means ± SEM. **P < 0.01 vs. 1 or 2.5 kPa, 
***P < 0.001 vs. 1 or 2.5 kPa, #P < 0.05 vs. 5 kPa, ###P < 0.001 vs. 5 kPa (Tukey’s 
test).  (B) The percentage of cells forming CDRs on gels derivatized with 0.2, 0.02, 
and 0.002 mg/ml collagen (n = 3 independent experiments). The dashed black line 
represents the half-maximal response. Data are means ± SEM.  
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4.4.2 Cell force is required for circular dorsal ruffle formation 
Recent data indicates that CDRs formation may be related to cell contractility (Zeng et 
al., 2011), and because our data showed that increased substrate stiffness promotes 
robust stress fiber formation, we asked whether stress fiber organization resulted in 
higher cell contraction and whether these forces are required for the formation of 
CDRs. Traction force microscopy was performed to quantify cell traction forces of 
VSMCs cultured on 2.5, 5, 10, and 30 kPa substrates (Figure 4.3A). Cells exhibited 
higher traction forces when cultured on stiffer substrates (Fig. 4.3B).  
 
 Our data indicate that cells that generate higher traction forces also exhibit 
more CDRs.  As such, we sought to determine whether force is a prerequisite for CDR 
formation. To upregulate or downregulate cell force, cells were treated with either 
calyculin A, an inhibitor of myosin light chain phosphatase, or ML-7, an inhibitor of 
myosin light chain kinase, respectively. Regardless of stiffness, cells treated with 
calyculin A increased their traction force generation significantly (Fig. 4.4A, green 
bars). Cells cultured on stiffer substrates that were treated with ML-7 exhibited lower 
traction forces compared to their respective untreated controls (Fig. 4.4A, blue bars). 
Notably, a higher percentage of cells pretreated with calyculin A formed CDRs in 
response to PDGF treatment compared to cells not treated with contractility-altering 
drugs. Conversely, significantly fewer cells formed CDRs when pretreated with ML-7, 
indicating that myosin light chain regulated cell contractility is necessary for robust 
CDR formation. 
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Figure 4.3. Substrate stiffness regulates intracellular pre-stress. (A) Representative 
traction force maps and phase images of A7R5 VSMCs on polyacrylamide gels. Scale 
bars, 50 μm. (B) The total magnitudes of cell traction force measurements with respect 
to substrate stiffness (n = 12-26 cells, 3 independent experiments). Data are means ± 
SEM. **P < 0.01, ***P < 0.001 (Tukey’s test).  
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Figure 4.4. Pharmacological control of cell force modulates CDR formation. (A) 
Traction force measurements of untreated (red bars, n = 12-26), calyculin A treated 
(green bars, n = 46-60), and ML-7 treated (blue bars, n = 37-51) cells. Data are means 
± SEM. *P < 0.05 compared to respective untreated controls (Tukey’s test). (B) The 
percentage of cells cultured on gels that exhibit CDRs (n = 3 independent 
experiments). Data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 compared 
to respective untreated controls (Tukey’s test). 
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Figure 4.5. Substrate stiffness upregulates MLCK activity to prime cells for robust 
CDR formation. (A) Representative immunofluorescent images of F-actin (green) and 
MLCK (red). White arrows indicate the localization of MLCK at CDRs. Scale bar, 50 
μm. (B) Representative immunoblot of Src and MLCK co-immunoprecipitation. (C) 
Representative immunoblots of phosphorylated MLC at residues threonine-18 and 
serine-19 and GAPDH with respect to substrate stiffness. 
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4.4.3 Substrate stiffness acts through myosin light chain to prime cells for 
circular dorsal ruffle formation 
It is widely accepted that substrate stiffness regulates cellular contractility, in part, 
through the myosin light chain (MLC) signaling pathway (Clark et al., 2007). In this 
pathway, myosin light chain kinase (MLCK) phosphorylates MLC, which enables 
actin-myosin mediated contraction. Interestingly, MLCK is also known to complex 
with Src (Barfod et al., 2011), a tyrosine kinase that mediates PDGF-induced CDR 
formation.  Because of its dual role in both the cellular contraction signaling cascade 
and in complexing with Src, we hypothesized that MLCK modulates PDGF-dependent 
CDR formation in response to increased substrate stiffness. Immunofluorescent 
staining indicates that MLCK colocalizes with CDRs (Fig. 4.5A). Additionally, 
MLCK and Src complex in A7R5 VSMCs, as evidenced by co-immunoprecipitation 
studies (Fig. 4.5B). However the amount of MLCK that complexes with Src does not 
change with stiffness. MLCK phosphorylates MLC at residues threonine-18 and 
serine-19 (Ikebe and Hartshorne, 1985), and as such, we asked whether substrate 
stiffness induces differential MLC phosphorylation through MLCK activity. Our 
results indicate that MLC phosphorylation at threonine-18 and serine-19 increases 
with substrate stiffness (Fig. 4.5C), indicating that MLCK activity is upregulated by 
stiffness. Together, our data indicate that substrate stiffness regulates cell contractility 
through modulating MLCK activity, resulting in increased MLC phosphorylation. 
When treated with PDGF, activated MLCK readily complexes with Src to form more 
CDRs on stiff substrates. 
 
4.4.4 Substrate stiffness increases PDGF-induced Src activity  
It has been shown previously that mechanically-induced Src activation is dependent on 
substrate stiffness and F-actin integrity (Na et al., 2008). Additionally, others have 
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found that an intact actin cytoskeleton is required for proper Src activation (Sandilands 
et al., 2004). Because our data and others have determined that substrate stiffness 
regulates actin cytoskeletal organization (Fig. 4.1A) (Zeng et al., 2011) and PDGF is 
known to induce CDR formation through a Src-dependent signaling cascade, we 
sought to determine whether substrate stiffness may regulate PDGF-induced Src 
activity. Lysates from PDGF-treated cells cultured on gels of varying stiffness were 
probed for Src phosphorylation at residue tyrosine 416, a marker for activated Src. 
Phosphorylation increases with substrate stiffness (Fig. 4.6), suggesting that PDGF-
induced Src activation is mediated by substrate stiffness. When Src was inhibited with 
pharmacological inhibitor PP1, VSMCs were unable to form CDRs regardless of 
substrate stiffness (data not shown). 
 
4.5 Discussion 
The migration of VSMCs from the medial layer into the intima contributes to the 
formation of plaques in atherosclerosis (Gerthoffer, 2007). This migration is thought 
to be stimulated by the release of growth factors, particularly PDGF, from endothelial 
cells (Evanko et al., 1998) or macrophages once they infiltrate into the vessel wall 
(Raines, 2004; Ross et al., 1990). Vascular stiffening accompanies atherosclerosis and 
is measured by clinicians to determine cardiovascular risk (Mattace-Raso et al., 2006; 
Sutton-Tyrrell et al., 2005). Research from our lab and others showed that vascular 
stiffening may promote endothelial permeability (Huynh et al., 2011; Krishnan et al., 
2011) and leukocyte transmigration (Stroka and Aranda-Espinoza, 2011; Sun et al., 
2011), hallmarks of atherogenesis. Here, we present data that implicate vascular 
stiffening to promote the formation of VSMC CDRs, structures believed to play a 
large role in initiating cell motility. 
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Figure 4.6. Src activity increases with substrate stiffness. (A) Representative 
immunoblots of phosphorylated Src (pSrc) and total Src. (B) The ratio of pSrc to total 
Src in cells cultured on gels of varying stiffness (n = 6 independent experiments). Data 
are means ± SEM. **P < 0.01 vs. 1 or 2.5 kPa, ***P < 0.001 vs. 1 or 2.5 kPa, #P < 
0.05 vs. 5, 10, or 30 kPa (Tukey’s test). 
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Our results indicated that CDR formation in VSMCs is dependent on substrate 
stiffness and collagen density. On more compliant substrates, cells displayed fewer 
CDRs compared to cells cultured on stiffer substrates (Fig. 4.2). Moreover, our data 
indicate that cell contractility is a prerequisite for CDR formation, and upregulation of 
cell force results in increased CDR formation (Fig. 4.4). Although the total magnitude 
of cell force increases with substrate stiffness, it remains to be seen whether local 
forces, particularly at sites of CDR formation, regulate actin dynamics to form CDRs. 
Substrate stiffness likely promotes the formation of CDRs through upregulation of 
MLC-dependent cell contractility. Interestingly, substrate stiffness also upregulated 
Src phosphorylation (Fig. 4.6), and inhibition of Src with PP1 prevented the formation 
of CDRs (data not shown).  
 
 It is widely accepted that, during atherosclerosis progression, VSMCs switch 
from a quiescent “contractile” phenotype to a migratory “synthetic” phenotype, where 
they are able to degrade their matrix and invade into the intima (Owens et al., 2004). 
Previous data suggests that PDGF signaling, which is both a potent migratory signal 
and initiator of CDRs, is a major contributing factor to the VSMC phenotypic switch 
(Raines et al., 2000). Our data suggests that the matrix stiffening that occurs 
concomitant with atherosclerosis progression may exacerbate phenotypic switching by 
increasing the percentage of cells that exhibit CDR formation in response to PDGF 
signaling. This is likely due to heightened MLCK activity of cells in stiffer 
microenvironments, as evidenced by our data showing MLCK colocalization with 
CDRs and increased MLC phosphorylation at resides threonine-18 and serine-19 (Fig. 
4.5). Several upstream activators may also directly contribute to CDR formation, 
particularly RhoGTPase and Rho-associated kinase (ROCK). RhoGTPase activity, 
which has been shown to increase with substrate stiffness (Huang and Ingber, 2005; 
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Huynh et al., 2011), activates ROCK, which also phosphorylates MLC at serine-19 to 
regulate stress fiber formation (Totsukawa et al., 2000). ROCK also functions to 
prevent myosin light chain phosphatase from deactivating MLC (Wang et al., 2009). 
Hence, it is likely that upstream RhoGTPase and ROCK are contributing to the 
generation of intracellular pre-stress priming cells for strong CDR formation. When 
treated with Y-27632, a ROCK inhibitor, VSMCs were unable to form robust CDRs 
(data not shown), similar to our results using ML-7 to inhibit MLCK and consequently 
CDR formation. Therefore, there is significant evidence that cell contractility is an 
important regulator of CDR formation.  
 
Previous data suggests that substrate rigidity enhances PDGF receptor 
phosphorylation intensity and length (Brown et al., 2010). Here we show that 
downstream of PDGF receptor phosphorylation, Src activity also increases with 
substrate stiffness (Fig. 4.6), resulting in increased CDR formation. Although the 
mechanisms behind Src phosphorylation leading to the formation of CDRs are not 
entirely understood, we and others found that Src localization is necessary for CDR 
formation (Azimifar et al., 2012). Recent studies by Azimifar and colleagues show 
that Src phosphorylation in response to growth factor stimulation is not sufficient for 
fibroblasts to form CDRs but that Src localization to focal adhesions by associating 
with integrin-linked kinase (ILK) is necessary for CDR formation. Because focal 
adhesions are also known to be regulated by matrix stiffness, this is consistent with 
our results where substrate stiffness regulates the activity of the Src-MLCK complex 
in forming CDRs in VSMCs (Fig. 4.5). It is not surprising then that Src, MLCK, and 
focal adhesion kinase (FAK) have been found to associate with one another to control 
adhesion turnover at the leading edge, resulting in lamellapodia protrusions and cell 
migration (Webb et al., 2004). 
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In addition to VSMC migration, our data also have implications in cancer, 
where stiffening of the tumor microenvironment has been shown to promote cancer 
cell migration and metastasis (Kumar and Weaver, 2009; Paszek et al., 2005; Wolf 
and Friedl, 2011). Invasive cancer cells form actin-based structures that are similar to 
CDRs in their protein makeup called invadopodia. Like CDRs, invadopodia are 
hypothesized to enhance cell migration (Ridley, 2011); however, they play a more 
significant role in cell invasion by releasing MMPs to degrade their surrounding 
extracellular matrix (Linder et al., 2011; Poincloux et al., 2009). Because invadopodia 
formation is also dependent on Src activity (Murphy and Courtneidge, 2011), our data 
suggests that substrate stiffness may also regulate invadopodia formation. Indeed, 
recent findings by Alexander and coworkers showed that breast carcinoma cells 
formed more invadopodia and degraded more of their matrix when cultured on stiffer 
substrates (Alexander et al., 2008). Although MMP2 has been shown to colocalize 
with CDRs (Suetsugu et al., 2003), the ability of CDRs to actively promote ECM 
degradation similarly to invadopodia has not yet been shown. To better understand the 
matrix degradation capacity of CDRs, it may be necessary to perform these 
experiments in 3D scaffolds since CDRs form on the dorsal side of cells.  
 
Here we provide evidence that vessel stiffening regulates the formation of 
CDRs in VSMCs. These structures likely contribute to the migration of VSMCs, 
possibly by phenotypically switching quiescent “contractile” VSMCs into more 
migratory “synthetic” cells through wide-scale actin rearrangement. Intracellular pre-
stress, which is modulated by matrix stiffness, primes cells for robust CDR formation. 
Collectively, our data suggests that the changes in vessel stiffness that accompany 
atherosclerosis enhance CDR formation and therefore contributes to the advancement 
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of disease. 
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CHAPTER 5 
 
EXPLORING BIOMECHANICS IN THE CLASSROOM 
 
5.1 Abstract 
 In June 2009, I was selected to be a fellow in the Cornell’s National Science 
Foundation Graduate STEM Fellows in K-12 Education (NSF GK-12) program. As 
part of this year-long fellowship, I had the pleasure and honor of working with Ms. 
Stacey Coston from Waverly High School to develop and give several lectures over a 
broad range of biomedical topics to students in 6th to 12th grade. Additionally, I 
developed two science labs that bring polymer science and cardiovascular 
biomechanics into the classroom. To introduce concepts of polymer science, students 
made “silly putty” from borax and glue. To introduce cardiovascular biomechanics, 
students built a model blood vessel out of rubber tubing to understand how vessel 
stiffness affects blood flow. This chapter chronicles my time as a GK-12 Fellow and 
overviews the teachings accomplished in Ms. Coston’s classroom. The language in 
this chapter diverges from the rest of the thesis as I describe the process of developing 
inquiry-based learning modules and the results and impacts of these modules on 
student learning. 
 
5.2 Introduction 
 As part of the NSF GK-12 Fellowship, I was paired with Stacey Coston, a 
teacher from Waverly High School who teaches taught Anatomy and Physiology and 
Forensic Science. We started our collaboration in the summer of 2009 by familiarizing 
her with several protocols in the Reinhart-King lab, including cell culture, 
immunofluorescent staining, and microscopy. Outside of the lab, we attended 
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meetings held by Dr. Chris Schaffer, Dr. Shivaun Archer, and Nev Singhota on the 
values and implementation of inquiry-based learning.  
 
 Inquiry-based learning (IBL) is a pedagogical philosophy that is gaining 
traction in science education (Bell et al., 2010). In IBL, rather than learning through 
rote memorization of scientific facts, students are tasked with developing and 
analyzing experiments and critically thinking about their results, skills that translate 
especially well to careers in science and research. Although the benefits of IBL over 
traditional learning methods are debated (Hmelo-Silver et al., 2007; Kirschner et al., 
2006), the goals of IBL are in line with the goals of the NSF GK-12 program, which 
are to better engage high school students in science and to develop problem solving 
skills.  
 
5.3 Results from Stacey’s summer research 
 To give Stacey a better understanding of how research is conducted in an 
academic setting, I supervised Stacey on a project that was related to vascular smooth 
muscle cell (VSMC) migration. The goal of her project was to understand how 
vascular stiffness and treatment with phorbol 12,13-dibutyrate (PDBu) affected cell 
migration. After learning cell culture, polyacrylamide gel synthesis, 
immunofluorescent staining, and time-lapse microscopy, Stacey performed 
experiments to analyze migration speeds of VSMCs with respect to substrate stiffness 
and PDBu treatment.  
 
 Below are figures Stacey created for a poster which represents the culmination 
of her summer research. In summary, Stacey found that VSMCs treated with PDBu 
formed podosomes, actin-rich adhesion structures that degrade extracellular matrix 
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(Gimona et al., 2008), potentially aiding VSMC migration and invasion (Fig. 5.1). 
These podosomes form and disassemble within minutes and may organize into ring-
shaped clusters (Fig. 5.2). By tracking cell movement over time and calculating mean-
squared displacements (Fig. 5.3), Stacey found that cells migrate slightly faster on 
stiffer substrates, and PDBu treatment further increased cell migration speeds (Fig. 
5.4). Persistence times, the time cells spend before significantly change migratory 
directions (Harms et al., 2005), decreased with PDBu treatment.  
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Figure 5.1. Representative immunofluorescent images of VSMCs on 10,000 Pa 
polyacrylamide gels stained for actin and α-actinin. Podosomes are evident in the 
untreated cells whereas form as clusters of dots (marked by white arrowheards) in 
PDBu-treated cells. Podosomes appear as dynamic structures when cells migrate and 
are often found on the leading edge of cell movement. 
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Figure 5.2. Time-lapse images of podosome formation in a VSMC on a 2,500 Pa 
polyacrylamide gel. The time indicated represents minutes elapsed after PDBu 
stimulation. As shown above, podosomes are dynamic structures that form and 
disassemble on the order of minutes. Arrowheads indicate the initial stages of 
podosome formation. 
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Figure 5.3. Representative mean-squared displacement data and cell movement plots 
of VSMCs without or with PDBu treatment.  
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Figure 5.4. VMSC migration speed increased slightly with stiffness and the addition 
of PDBu. PDBu has been found to upregulate stress fiber and focal adhesion 
disassembly and actin polymerization. Persistence time decreases with addition of 
PDBu. This may occur because PDBu causes VMSC to actively undergo cytoskeletal 
rearrangement. 
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5.4 Development of curricular materials 
 In addition to performing research, Stacey worked with me to develop new 
curriculums that would educate her students about cutting edge research. I had a 
different role than most other NSF GK-12 Fellows in that I was a “Guest Lecturer” in 
addition to being a “Resident Scientist” who helped with lab activities. One of our 
goals was to translate some of the research she performed while in our lab into 
engaging material for her students. One concept that is universally understood is that a 
single cell is the smallest unit of life; however, the majority of students at the high 
school level fail to realize that cells are capable of sensing and responding to their 
environment, much like whole organisms. To teach this to students, I developed a 
lecture that explained the concepts of cell-cell communications. The advent of 
Youtube is particularly helpful in communicating science to students. In this lecture, 
which can be found in Appendix E.2., I liken cell signaling cascades to a Rube-
Goldberg machine where a series of processes must occur correctly for cells to 
respond to their environment. To show cell sensing and environmental response, I 
used a particularly engaging video captured by the late David Rogers of Vanderbilt 
University that shows a neutrophil tracking down and killing bacteria.  
 In addition to lecturing about cell communications, I created several other 
lectures that introduce biomedical concepts to Stacey’s students. Some of the lectures, 
like those on bioterrorism and cancer, were created in response to a student survey that 
gauged their scientific interests. Other lectures focused on the applications and 
potential of nanotechnology, tissue engineering, and prosthetic heart valves. Due to 
the generosity of Jonathan Butcher’s lab, I used sample heart valves as props in one 
lecture. All of these lectures have been included in Appendix E. 
 During my time at Waverly High School, I also served as a mentor who 
provided career advice to rising juniors and seniors. Because I am closer to the 
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students in age and obtained my undergraduate degree more recently, Stacey thought 
that I would be an invaluable source of information for students who were considering 
higher education. We developed a lunch seminar where interested students were 
encouraged to ask any questions they wanted. Some questions that stood out were 
about deciding on an undergraduate major, dorm life and social activities, graduate 
education, careers and opportunities in science, and the undergraduate experience in 
general.  
 
5.5 Inquiry-based labs 
I developed two labs aimed to teach students the importance of stiffness in the 
progression of cardiovascular diseases. In the first lab, titled “Elasticity of blood 
vessels,” the students explored the role of blood vessel elasticity on the flow of blood 
using plastic tubing to model the circulatory system. In the second lab, titled “Polymer 
chemistry: physical properties of gels,” students were asked to make silly putty and 
design an experiment to characterize the stiffness of their silly putty, which varied 
based on the amount of polymer and crosslinker they used.  
 The blood vessel elasticity lab was more straightforward and less inquiry-
based. In this lab, students attached several pieces of plastic tubing between a 
basketball pump and a beaker full of water (Appendix E.1.3). When pumped, the flow 
of air through the tubes resulted in bubbles that arise from the beaker, representing the 
flow of blood. The students were then made to change type of tubing to see how that 
changed the severity of the bubbling. They were given two different stiffnesses of 
latex, one colored pink which was thin and very compliant, the other colored amber 
which was thicker and stiffer. When students used these tubes to make their model 
blood vessel, they found that the pink elastic latex resulted in much less violent bubble 
formation in the beaker. This model mimics a more elastic vessel in the body, whereby 
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vessel expansion slows the rate of blood flow and allows for more continuous blood 
flow. Inelastic vessels do not expand and increased blood flow is found. The students 
also modeled the occurrence of an aneurysm by plugging the tubes such that air flow 
does not move through. In this case, the pink latex balloons outward, thinning and 
stiffening.  
 The polymer science lab was much less structured than the vessel elasticity lab 
and could be considered a guided-inquiry lab. In the beginning of the lab, students in 
groups of 3-4 were instructed to mix a 4-to-1 ratio of glue-to-borax to obtain silly 
putty. After qualitatively characterizing some of its properties, such as viscoelasticity 
and stiffness, the students were allowed to make silly putty from whatever ratios of 
glue-to-borax they wanted. The addition of food coloring gave students another level 
of freedom and creativity, and the students highly enjoyed making and playing with 
various polymers. 
 The defining moment of the lab was when students started running 
experiments to quantitatively characterize the stiffness of their various ratios. I 
provided rulers and stopwatches so students could take time and distance 
measurements, but I did not give them any hints as to how to compare their gels with 
one another. I was very pleased when students developed several different 
experiments to characterize their gels. Because silly putty is viscoelastic, it “flows” in 
response to gravity. Using this concept, one group measured the distance their gels 
lengthened when held in the air for 10 seconds, while another group record the time it 
took for gels to lengthen 12 inches. Other students shaped the gel into a sphere, placed 
the ball on the table, and measured the time it took to flatten to a certain diameter. 
Another group dropped balls of silly putty from a certain height and measured the 
rebounding height, using that to characterize their polymer’s stiffness.  
 Following the collection of data, groups presented their findings. Interestingly, 
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some groups found that some ratios did not form polymers, while some groups found 
conflicting results even though they used the same ratios as other groups. We ended 
the activity with a summary of results from the students and an explanation for the 
discrepancies in results between groups. We discussed the concept of experimental 
controls and consistency between experiment runs. For example, many groups did not 
control for initial gel size, either by measuring the mass or perhaps the circumference 
of the sphere before it started to deform. The students learned that a different approach 
to quantifying their data would be to calculate a percent change from their initial 
measurements.  
 
5.6 Results from the lab exercises 
To gauge whether students learned from the labs, I administered a 10 question quiz 
(Appendix E.1.5) immediately before and approximately 4 weeks after the labs. The 
results are shown in Fig. 5.5A. In the post-test, the students improved about 3.5 points 
in their scores, indicating that they still remembered what they learned from the labs. 
Fig. 5.5B summarizes the performance of students with respect to the question 
number. The students improved drastically in 8 of the 10 questions.  
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Figure 5.5. Pre- and post-test results of the atherosclerosis quiz. (A) Post-test scores 
were significantly higher than pre-test scores. Data are means ± SD (n = 21 students). 
***P < 0.001 (Student’s t-test) (B) The percentage of students that answered each 
question correctly is plotted pre- and post-test.  
 
  
 144 
5.7 Conclusions 
My goal was to engage Stacey’s high school students in science and technology. I 
believe that through the various lectures and inquiry-based labs that we administered, 
the students were able to expand their knowledge of science, understand possible 
applications of science, and get an idea of how to design and conduct experiments. My 
appointment as an NSF GK-12 Fellow was an invaluable experience that taught me 
how to communicate science more effectively and grow as a mentor. The questions I 
received from students during my experience taught me to think quickly to explain 
difficult or confusing concepts using analogies to reach a wider audience. I also 
learned to use inquiry-based learning to teach, engage, and challenge students. 
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CHAPTER 6 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 Conclusions 
As our knowledge of atherosclerosis continues to expand, particularly of its origins 
and pathogenesis, so too will our ability to develop therapeutics to prevent or reverse 
the progression of atherosclerosis. This thesis contributes to the knowledge of 
atherogenesis by identifying age-related vascular stiffening as a potent inducer of 
endothelial permeability, an initiating step of atherosclerosis, and also of vascular 
smooth muscle cell migration, which occurs in the later stages of atherosclerosis. 
Using tunable matrices that mimic the stiffness of healthy and aged vessels, this work 
demonstrates that endothelial and vascular smooth muscle cells cultured on stiffer 
matrices exhibit atherosclerotic phenotypes. Additionally, the pharmacological 
inhibition of stiffness-induced cell contractility may potentially mitigate the 
progression of atherosclerosis.  
 
 In Chapter 2, we developed a novel method for assaying the permeability of 
tracer molecules through an endothelial monolayer cultured on soft, porous substrates. 
Because the stiffness of porous membranes used in traditional permeability studies are 
orders of magnitude higher than that of native blood vessels, the development of a new 
permeability assay that matches physiological stiffness was required. Using confocal 
microscopy, our technique detects the amount of FITC-conjugated dextran that 
permeates through an endothelial layer and accumulates within the underlying 
polyacrylamide gel. By measuring the fluorescent intensity of the entrapped 
molecules, the relative permeability of the endothelial cells can be determined as they 
 147 
are subjected to varying stiffnesses or drug treatments.  
 
This method is has some advantages over traditional Transwell membrane 
assays because in those assays, the membranes are stiff plastics that do not represent 
physiological stiffness. Additionally, transmembrane studies generally take hours for 
tracer molecules to move a detectable amount through the membrane. Increased data 
variability is also a concern because of repeated sampling from the Transwell to be 
used in spectrophotometric absorbance measurements. Our permeability measurement 
method holds advantages in that the movement of tracer molecules can be detected 
within minutes and is real-time with confocal scanning.  
 
Although our method has clear advantages, it is not without limitations. On 
very stiff substrates where the void fraction of the gel is small, only a certain amount 
of tracer molecules will be able to accumulate within the gel before the gel is 
saturated. In our studies, cells cultured on 30 kPa gels did not show increased 
permeability in response to thrombin, possibly indicating that 30 kPa gels are saturated 
by FITC-dextran within 5 minutes. A possible way to overcome this limitation is to 
perform shorter experiments on the order of 1 to 2 minutes of dextran diffusion, which 
may allow for the detection of endothelial permeability before the gel becomes 
saturated. Additionally, it may be possible to polymerize 30 kPa gels that have a larger 
void fraction by optimizing the total acrylamide and crosslinker amount (Charest et 
al., 2012; Rüchel et al., 1978). Taken together, the work described in Chapter 2 
expands upon traditional permeability assays to account for substrate stiffness. 
 
Using our newly developed permeability assay, we explored the effects of 
substrate stiffness on endothelial permeability, a hallmark of atherosclerosis, in 
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Chapter 3. The work presented in this chapter is the first to directly measure 
endothelial permeability in response to substrate stiffness. Our data indicated that 
increased substrate stiffness results in increased endothelial permeability, widening of 
endothelial cell-cell junctions, and increased leukocyte transmigration through 
endothelial cell monolayers. One of the most impactful findings of this study was that 
pharmacological inhibition of stiffness-induced ROCK-dependent endothelial cell 
contractility reversed all three of the aforementioned events. In addition to reversing 
hallmarks of atherosclerosis in vitro, inhibition of ROCK reduced cell-cell junction 
widths and vessel permeability in vivo using a mouse model. Therefore, 
pharmacological inhibition of endothelial cell contractility may be a potential 
treatment to slow or prevent the progression of atherosclerosis. 
 
Although the work described in this thesis suggests that ROCK inhibition may 
potentially slow or prevent atherosclerosis, dosage remains a significant concern. In 
our experiments, cells in vitro were treated with Y-27632 for 30 minutes. In 
comparison, van Nieuw Amerongen and colleagues found that prolonged Y-27632 
treatment of endothelial cells for 24 hours or more resulted in less VE-cadherin 
accumulation at cell-cell junctions and increased permeability (van Nieuw Amerongen 
et al., 2007), indicating possible negative effects of prolonged ROCK inhibition. 
Additionally, because ROCK is present in many other cell types including leukocytes 
and smooth muscle cells, off-target effects of ROCK inhibition should be 
characterized and minimized to ensure drug safety. However, once the safety and 
dosage of ROCK inhibition is elucidated, targeting endothelial cell contractility to 
prevent permeability and leukocyte extravasation remains an attractive therapeutic 
approach to slowing atherosclerosis.  
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Other potential therapeutic targets include integrin and focal adhesion kinase 
(FAK) signaling, which are upstream of RhoGTPase and ROCK activity and are 
utilized in mechanosensing. By reducing integrin or FAK activity, it may be possible 
to elicit similar decreases in cell contractility as ROCK inhibition to reverse hallmarks 
of atherosclerosis. Likewise, inhibition of myosin light chain downstream of 
Rho/ROCK may induce comparable responses. Alternatively, inhibiting the 
expression of endothelial adhesion molecules may be an attractive approach to 
decreasing leukocyte attachment and transmigration phenotypic of atherosclerosis.  
 
 In Chapter 4, the effects of vessel stiffening on vascular smooth muscle cell 
circular dorsal ruffle formation were investigated. Our data indicated that increased 
substrate stiffness promotes CDR formation. Because CDRs are recognized to provide 
wide-scale cytoskeletal rearrangements that promote cell motility, stiffness-induced 
CDR formation may encourage VSMC migration in the later stages of atherosclerosis. 
We determined that increased VSMC contractility due to substrate stiffness promotes 
CDR formation. Interestingly, pharmacological inhibition of cell-generated forces 
prevents CDR formation. This result is not unlike our results using endothelial cells, 
where inhibition of cell contractility reversed hallmarks of atherosclerosis. Together 
with the results from previous chapters, this work indicates that cell contractility 
inhibitors have therapeutic potential in preventing several hallmarks of atherosclerosis, 
namely endothelial permeability, leukocyte transmigration, and VSMC migration and 
invasion.  
 
The findings presented in this dissertation not only help us understand the role 
of matrix stiffness in atherosclerosis, but also the complex relationship between cell-
ECM and cell-cell interactions. The knowledge gained through these experiments 
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could be used in the design of tissue engineered scaffolds that better control cell 
phenotypes, or therapeutics that block cell-ECM interactions, thereby slowing the 
pathogeneses of stiffness-related diseases such as atherosclerosis and cancer 
metastasis.  
 
6.2 Future directions 
Although the work described in this dissertation contributed to our knowledge of 
atherosclerosis, additional work is required to fully understand the role of mechanical 
stimuli in dictating the progression of atherosclerosis.  
 
One advantage of the polyacrylamide gel system that was not explored in this 
study is the ability to coat the surface with various ECM proteins. During the 
progression of atherosclerosis, fibronectin is deposited at atheroprone sites and 
contributes to endothelial dysfunction (Feaver et al., 2010; Sottile and Hocking, 
2002). Our system is well adapted to study the effects of different ECM proteins, such 
as fibronectin, on endothelial permeability and traction generation. Preliminary data 
indicates that endothelial cells exhibit increased permeability when cultured on 
fibronectin-derivatized gels compared to collagen-derivatized gels (Fig. 6.1). 
 
 In addition to endothelial permeability, future work should elucidate the role of 
substrate stiffness on endothelial dysfunction. Our own work showed that the 
expression of adhesion molecules ICAM-1, VCAM-1, and E-selectin was not 
dependent on substrate stiffness. However, there are many other markers of 
endothelial dysfunction, including reactive oxygen species (ROS) generation 
(Hulsmans and Holvoet, 2010; Kondo et al., 2009) and decreased nitric oxide (NO) 
production (Lubos et al., 2008; Thomas et al., 2008), which are also hallmarks of 
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atherosclerosis. The study of these events with respect to substrate stiffness may 
further tie age-related vessel stiffening with atherosclerosis. 
 
   
 
 
 
 
 
 
 
Figure 6.1. Effect of extracellular matrix type on endothelial permeability. Data are 
means ± SEM. *P < 0.05 (Student’s t-test).   
 
 152 
Future work should also investigate other mechanical stimuli, such as flow-
mediated shear stress, in combination with substrate stiffness. Within the vasculature, 
atherosclerotic plaques tend to develop in specific regions where flow is disturbed 
(VanderLaan et al., 2004). Shear stress plays a crucial role in the localization of 
atherogenesis and dictates endothelial phenotype (Hahn and Schwartz, 2009). Steady, 
laminar, atheroprotective flow maintains endothelial alignment and integrity, whereas 
disturbed, atheroprone flow promotes permeability (Ogunrinade et al., 2002) and 
junctional reorganization (Melchior and Frangos, 2010) and separation (Malek et al., 
1999). Interestingly, many of the signaling pathways utilized in response to substrate 
sensing and flow sensing overlap (Shyy and Chien, 1997). The study of both substrate 
stiffness and shear stress in combination would greatly expand our knowledge of the 
contributions of mechanical stimuli in disease progression.   
 
In addition to shear stress, advanced glycation end-products (AGEs) are 
thought to contribute to endothelial dysfunction and atherosclerosis. AGEs are 
produced by the nonenzymatic reaction between proteins and reducing sugars (Zieman 
and Kass, 2004) and interact directly with endothelial cells through the receptor for 
advanced glycation end products (RAGE), causing impaired endothelial function (Lin 
et al., 2009; Yan et al., 2007). The accumulation of AGEs with age also leads to the 
crosslinking of vessel matrix and increased stiffening (Greenwald, 2007). It would be 
interesting to study the relationship between substrate stiffness, AGE-signaling, and 
endothelial function. Recent work has already implicated AGE-signaling to induce 
endothelial permeability by activating cell contractility (Hirose et al., 2010). 
 
 Much of the work presented in this dissertation describes the measurement of 
traction forces generated by cells in response to their matrix. However, the study of 
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forces generated between cells at their junctions may also help to explain the 
maintenance of endothelial barriers. The work described by Maruthamuthu and co-
workers sough to understand the relationship between cell-ECM forces and cell-cell 
forces (Maruthamuthu et al., 2011). Future work in endothelial cell-cell force 
measurements may provide insights into the ability of cells to create tension through 
VE-cadherin bonds to regulate endothelial permeability.  
 
 Although the work presented in Chapter 4 of this thesis indicates that ROCK 
inhibition decreases endothelial permeability in mice, it would be worthwhile to study 
the therapeutic potential of ROCK inhibition in mice that develop atherosclerosis. An 
established mouse model of atherosclerosis is the apolipoprotein E-deficient (apoE-/-) 
mouse, which exhibits lipid abnormalities (Buzello et al., 2003), elevated serum 
plasma cholesterol, and impaired clearance of plasma lipoproteins (Imaizumi, 2011). 
These experiments may provide insights as to whether ROCK therapy can prevent the 
permeation and deposition of lipoproteins in younger mice that presumably have more 
compliant vessels, but readily develop atherosclerosis. More long-term studies should 
elucidate the therapeutic potential of ROCK inhibition by characterizing the number 
and size of atherosclerotic lesions that form within apoE-/- mice. Kaplan-Meier 
survival plots may provide an additional understanding of the benefits of ROCK 
inhibition in extending life. 
 
 Our work implicated substrate stiffness as an inducer of circular dorsal ruffle 
formation in vascular smooth muscle cells. As the mechanisms and machinery behind 
CDR formation are elucidated, future work with CDRs should focus on understanding 
its formation in 3D matrices for two reasons. First, three-dimensional scaffolds better 
mimic the physiological environment in which VSMCs are found. Second, CDRs 
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form on the dorsal side of cells, requiring the use of 3D matrices to fully understand 
their behaviors and functions. Because our work indicates that force generation 
regulates CDR formation on 2D substrates, traction force measurements of cells in 3D 
may provide insights to the role of cell contractility in inducing CDR formation in 3D. 
Studies performed by Legant and colleagues show the feasibility of measuring traction 
forces in 3D (Legant et al., 2010). Lastly, MMP2 has been shown to localize at CDRs 
(Suetsugu et al., 2003), indicating that CDRs may potentially have a role in matrix 
degradation and cell invasion. Future work should explore MMP secretion and ECM 
degradation at CDR sites within 3D matrices to better understand the function of 
CDRs.  
 
 Ultimately, future directions of this work will provide additional insights into 
the role of vessel stiffening in endothelial dysfunction and VSMC migration typical of 
atherosclerosis, as well as potential therapies and biomaterial designs for preventing or 
treating atherosclerosis. 
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APPENDIX A 
 
PERMEABILITY MEASUREMENTS OF ENDOTHELIAL CELLS ON 
POLYACRYLAMIDE GELS 
 
Materials: 
Timer 
Forceps 
35 mm petri dishes 
10 μM 40 kDa FITC-dextran in L-15 media 
 
Protocol: 
1. Culture endothelial cells to 100% confluency on 18 mm circular 
polyacrylamide gels in 6-well plates. 
2. Two-days post-confluence, refresh cells with warm Leibovitz’s L-15 media 
and place in a non-CO2 incubator at 37 °C. Allow to equilibrate for at least 4 
hours. 
3. Make enough 10 μM solution of 40 kDa FITC-dextran for all of your samples. 
Each sample requires 2 ml of dextran solution. For example, for 25 samples, 
make 50 ml of dextran solution by dissolving 0.02 g 40 kDa FITC-dextran into 
50 ml L-15 media. Mix by vortexing. 
4. For each sample, aliquot 2 ml of dextran solution into a 35 mm petri dish. 
Place these petri dishes in the non-CO2 incubator to warm to 37 °C. 
5. Turn on the Leica TCS SP2 confocal microscope. Only turn on the 488 laser 
and bring the power to the 9 o’clock position.  
6. Open the Leica software and move the objective to the 40x dipping lens. Set 
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the beam to the “FITC” configuration. Move the laser power up to ~50%. Set 
the mode to “xzy”. Set line averaging to 4. Ensure the pinhole is of airy 1. See 
Fig. A.1 below.  
7.  Using forceps, move a gel from the 6-well plate into a dextran-filled 35 mm 
petri dish. Start a timer for 5 minutes. Place everything back in the incubator. 
8. When you have ~1.5 minutes left, place the 35 mm petri dish on the confocal 
microscope using the metal dish holder or a glass microscope slide. Insert the 
dipping lens into your sample. Start live scanning on the confocal software. 
Locate your gel by moving the stage up and down.  
9. Using the Q-LUT, adjust your gain and offset so that there are just a few 
overexposed pixels (blue) for the FITC-dextran solution and underexposed 
pixels (green) for the glass beneath the gel. The gain is usually around 550 V, 
and offset around -4%. 
10. Once the timer hits 0:00, acquire 4 images in quick succession near the center 
of the polyacrylamide gel. 
11.  Repeat with all samples. 
12. Pro-tip: while waiting for timer to count down before step 8, you can place 
another gel in dextran and start a second timer to stagger your samples every 
~3 minutes. 
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Figure A.1. Settings for Leica TCS SP2 confocal for permeability image acquisition. 
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APPENDIX B 
 
SEEDING AND LYSING CELLS ON POLYACRYLAMIDE GELS FOR 
WESTERN BLOTTING ANAYLSIS 
 
Materials: 
For cell seeding: 
Cell suspension 
Kimwipes 
Razor blade 
100 mm petri dishes 
 
For cell lysing: 
Ice cold PBS 
Ice cold lysis buffer 
Ice cold 100 mm petri dishes 
Razor blade 
Kimwipe 
Labeled ice cold 1.7 ml centrifuge tubes 
Cell scrapers 
Liquid nitrogen 
 
Protocol: 
1. Make 48 x 65 mm polyacrylamide gels by using 300 μl of gel solution per 
activated glass slide. Store at 4 °C until ready to use. 
2.  Remove gel from storage using a razor blade. Dry edges and the glass backing 
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of gels using a Kimwipe. 
3. Place gel in a new, dry 100 mm petri dish. 
4.  Seed 2 ml of cells onto the polyacrylamide gel, creating a “bubble” of media 
on top of the gel. 
5.  Carefully place in incubator without disrupting the bubble of media. 
6.  Allow cells to attach for ~4 hours. Then add 8 ml media to the culture dish and 
culture normally. 
7. When ready to lyse, prepare ice cold lysis buffer. Chill new 100 mm petri 
dishes at -20 °C. Chill PBS to ice cold temperature.  
8.  Place a chilled 100 mm petri dish on ice. Add 150 μl lysis buffer to the center 
of the petri dish. 
9.  Using a razor blade, remove polyacrylamide gel from culture and rinse both 
sides of the gel several times with at least 8 ml ice cold PBS.  
10.  Dry the glass backing and edges of the gel using a Kimwipe. Invert gel cell-
side down onto lysis buffer. 
11. Using a cell scraper, gently rotate the gel around in the petri dish, mechanically 
shearing cells off the gel. 
12.  Remove the gel from lysis buffer using a razor blade and collect as much 
lysate off the gel using the cell scraper, adding it to the petri dish. 
13. Collect as much lysate as possible from the petri dish using the cell scraper. 
14. Aspirate cell lysate and place in an ice cold 1.7 ml contribute tube.  
15.  Centrifuge at desired speed (14,000 x g) for desired time (5 min) at 4 °C. 
16. Collect supernatant and place in a fresh 1.7 ml centrifuge tube.  
17.  Snap-freeze in liquid nitrogen and store at -80 °C until ready for Western blot 
analysis. 
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APPENDIX C 
 
siRNA TRANSFECTION OF BOVINE AORTIC ENDOTHELIAL CELLS 
 
Materials: 
20 μM siRNA 
Lipofectamine 2000 
15 ml centrifuge tubes 
Complete media without pen/strep 
OptiMEM 
 
Protocol: 
1.  Grow endothelial cells to desired confluency (90%) in 6-well plates. 
2.  Refresh cells with 2 ml complete media without pen/strep and place cells back 
in incubator. 
3.  In the hood, per sample, combine 250 μl OptiMEM with 5 μl Lipofectamine 
2000 in a 15 ml centrifuge tube. Mix well by pipetting. In another centrifuge 
tube, combine 250 μl OptiMEM with 1.25 μl siRNA per sample and mix by 
pipetting. Allow these two tubes to incubate at room temperature for 15 
minutes. 
4. Combine the Lipofectamine solution with the siRNA solution. Mix well by 
pipetting and incubate at room temperature for 15 minutes. 
5.  Add 500 μl of the siRNA/Lipofectamine solution to each well of your 6-well 
plate.  
6. Incubate cells at 37 °C for 4 hours to allow for transfection. 
7. Refresh cells with complete media (with pen/strep). 
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8.  Run experiments two-days post-confluency. 
9. Pro-tip: The concentration of siRNA described above is 10 nM 
(stock 20 μM siRNA * 1.25 μl / 2.5 ml total media = 10 nM). You may have to 
play with the concentration of siRNA to optimize transfection. 
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APPENDIX D 
 
CO-IMMUNOPRECIPITATION 
 
Materials: 
Ice cold PBS 
Ice cold lysis buffer 
Ice cold 100 mm petri dishes 
Razor blade 
Kimwipe 
Labeled ice cold 1.7 ml centrifuge tubes 
Cell scrapers 
Rotator 
Protein A or protein G agarose beads 
 
Protocol: 
1. On ice, lyse cells on 48 x 65 mm gels using 200 μl lysis buffer. Collect lysate 
into an ice cold 1.7 ml centrifuge tube. 
2. Centrifuge for 10 minutes at 14,000 x g at 4 °C. Move supernatant to a newly 
labeled ice cold tube. 
3.  On ice, add 200 μl lysis buffer and 2 μl antibody to lysate (1:200 dilution).  
4.  Incubate 1-12 hr or overnight at 4 °C under gentle agitation/rotation. 
5.  Using a cut pipette tip, add 8 μl protein A or G beads (for 400 μl lysate) and 
incubate at 4 °C on rocker/rotator for 2 hr to overnight 
6.  Collect immunoprecipitates by centrifugation at 1,000 x g (2,500 rpm) for 5 
min at 4 °C. Discard supernatant. 
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7.  Wash pellet 3 times with 500 μl lysis buffer by mixing with beads and 
centrifuging as described in step 6.  
8.  Discard supernatant. Add 30 μl lysis buffer and 10 μl 5X SDS and heat/boil 
sample at 100 °C for 5 min. 
9.  Centrifuge beads at 1,000 x g and run the supernatant on SDS-PAGE. 
10. Pro-tip: Antibody dilution in step 3 may need optimization. Check antibody 
product sheet for starting dilution (typically 1:100). 
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APPENDIX E 
 
GK-12 TEACHING MATERIALS 
 
E.1.1 Cornell BME CLIMB Module 
 
The Mechanics of Atherosclerosis 
Authors:   John Huynh and Stacey Coston 
Date Created:  2010 
Subject:  Biology, Chemistry 
Level:  Grades 9-12 
Standards:  The Living Environment: 1-Scientific Inquiry: 1.1a, 1.2a, 1.3b; 2-
Scientific testing: 2.1, 2.3, 2.4; 3-Analysis of results: 3.1; 4-Content: 
1-Living Things: 1.2a,b,c,d,e,f; 5-Dynamic Equilibrium: 5.2a,h,j, 
5.3. 
Schedule:  Polymer lab: 90 minutes or two class periods 
Blood flow lab: 45 minutes or one class period 
 
 
Objectives: 
 
To understand the mechanical 
mechanisms that underlie the 
progression of atherosclerosis 
Students will: 
 
Vocabulary: 
Atherosclerosis 
Cardiovascular Disease 
Aneurysm 
Polymer 
Cross linker 
Young’s modulus 
 
Materials: 
For Each Group: 
Polymer Lab: 
Sharpie 
10 Zip lock bags 
One cup of 50% Elmer’s glue 
One cup of 4% Borax 
2 Plastic spoons 
Timer/stopwatch 
Ruler 
Food coloring 
Activity Sheet #1 for each student 
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• Be introduced to polymer chemistry 
• Fabricate gels of varying stiffness 
• Design experiments to quantify gel 
stiffness 
• Understand how arterial stiffness 
contributes to disturbed blood flow 
and the progression of 
atherosclerosis 
• Communicate their findings to group 
mates and the class 
 
 
Blood Flow Lab: 
Basketball pump with nozzle attachment 
600 mL Beaker half filled with water 
Clear PVC tubing (5/16” I.D. x 1/2” 
O.D.) 
Amber latex tubing (1/2” I.D. x 5/8” 
O.D.) 
Non-lubricated condoms 
Cable ties 
Activity Sheet #2 for each student 
 
Safety:________________ 
Be careful not to get Borax in the eyes. 
If this happens, please flush eyes with 
water for 10 minutes. Alternatively, 
wear safety goggles. Students who are 
allergic to latex should not handle latex. 
 
 
Science Content for the Teacher: 
 
 Cardiovascular diseases are the leading cause of death in the United States, 
claiming more lives than cancer, car accidents, and HIV combined in 2006. 
Approximately 25% of Americans have some form of cardiovascular disease. 
Atherosclerosis is a disease of the arteries where the accumulation of lipids, 
cholesterol, and white blood cells harden the blood vessel. These atherosclerotic 
plaques may lead to the formation of a thrombus that occludes the artery. 
Atherosclerosis is considered a “silent killer” since it is typically asymptomatic and 
manifests itself as catastrophic events such as heart attacks or strokes. 
 
 Recent research suggests that mechanical stresses experienced in the 
vasculature may contribute to the progression of atherosclerosis. Atherosclerosis is 
often found in areas with disturbed blood flow which resemble turbulent whirlpools 
instead of steady streams of flow. These areas are predominantly found where blood 
vessels branch or bifurcate. Imagine a stream of water that encounters a large rock. 
The water will crash into the rock and then flow turbulently around it.  
 
 In response to disturbed blood flow, cells remodel their microenvironment by 
changing the composition of their extracellular matrix (collagen, elastin, laminin), 
which leads to increases in blood vessel stiffness. This increase in stiffness may act as 
a feedback loop that causes cells to continue to remodel and stiffen their 
microenvironment. Interestingly, as we age, 100% of the population exhibits vessel 
stiffening which correlates with risk of cardiovascular disease.  
 
 Healthy, elastic arteries stretch and store fluid as a pulse of blood is pumped by 
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the heart. As the vessels recoil, blood is continuously moved through the vasculature. 
Stiffened arteries lose their elasticity which results in elevated blood pressures and 
dysregulated blood flow.  
 
 To study the effects of mechanical stiffness on cell behavior, scientists culture 
cells on gels with tunable mechanical properties. By simply varying the ratio of 
polymer to its cross-linker (hardener), scientists can synthesize gels of varying 
Young’s moduli, a measure of stiffness. Gels can be made with a stiffness of a few 
hundred Pascals which resembles brain or fat tissues, or several thousand Pascals 
which resemble muscle tissues or collagenous bone.  
 
Preparation: 
 
Pre-lab lecture: A day before the labs, the teacher should introduce the concept of 
cardiovascular diseases and describe the progression of atherosclerosis. The effects 
of blood flow and blood vessel stiffness on atherosclerosis progression should be 
emphasized. Additionally, the use of gels of varying stiffness in scientific research 
should be mentioned. See “Science Content” above and lecture slides link. 
 
Polymer Lab: 
1. Make 50% Elmer’s glue solution by adding a 1:1 ratio of Elmer’s glue and 
water in large container, such as a 1 quart plastic jar, and shaking/stirring 
vigorously until there are no clumps of glue. Label this “Solution A.” 
 Recommended: 6 bottles of Elmer’s glue to the same volume of water. 
2. Make 4% Borax solution by adding 4g of Borax per 100 ml warm water and 
mixing well. This can be approximated by adding 2 teaspoons of Borax to 
1 cup of warm water. Label this “Solution B.” 
 Note 1: Warm water helps Borax dissolve completely. 
 Note 2: Borax (sodium tetraborate) can be found online at Amazon.com or 
grocery stores in the household cleaners section. A commonly labeled 
brand is “20-Mule Team.” 
3. Provide for each group (3-4 students) 1 Sharpie, ~10 zip lock bags, a plastic 
cup half filled with Solution A, a plastic cup half filled with Solution B, 2 
plastic spoons, a timer/stopwatch, a ruler, and some food coloring. 
4. Provide each student with Activity Sheet #1 
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Blood Flow Lab: 
 
 
1. Each group needs 2 pieces of clear PVC tubing, one that is 1foot long, and 
another that is 3 feet long. Cut enough for the class. Tubing is available 
through Amazon.com (I.D. 5/16” x O.D. 1/2”, ASIN# B000FN0OMQ for 
25 ft, ASIN# B000FMULGQ for 100 ft) 
2. Cut amber latex tubing into 6 inch pieces. Tubing is available through 
Amazon.com (I.D. 1/2” x O.D. 5/8”, ASIN# B001UI1208)  
3. Cut each prophylactic into 6 inch tubes. 
4. Provide for each group a basketball pump with the white nozzle attachment, 
a one foot long piece of clear tubing, a three foot long piece of clear tubing, 
1 amber latex tubing, 1 cut prophylactic, 4 cable ties, and 1 beaker half 
filled with water.  
5. Provide each student with Activity Sheet #2 
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Classroom Procedure: 
 
Polymer Lab: 
 
Engage (Time: 5 min) 
 
Introduction to concepts should have been discussed previously. Have all materials set 
out for student groups. Explain to students that they will assume the role of scientists 
and explore a chemical reaction that results in the synthesis of a gel. Emphasize that 
they will be designing their own experiments. 
 
Explore (Time: 50 min) 
 
Allow students to work through Activity Sheet #1. Be aware of students who are too 
busy playing with the gels and not progressing through the worksheet. Help students 
brainstorm ways to design their own experiments; remind them that they are allowed 
to use timers and rulers. If additional materials are available in the classroom, let 
students use them to design experiments. 
 Examples:  
1. Record the time it takes for a gel to stretch 10 inches when held in mid-
air. 
2. Record the length a gel stretches over 30 seconds. 
3. Turn the gel into sphere and measure its initial diameter. Let the ball sit 
on a table for 60 seconds and then measure its diameter. 
4. Turn the gel into a sphere and drop from table height. Record the height 
the ball bounces. 
 
Explain (Time: 35 min) 
 
 Allow groups to present their experiments to the rest of the class. Have groups 
present their method of quantification and their results. Have the rest of the class ask 
questions and critique methods. Example question: “Did you make sure all gels were 
equal size and shape before letting them stretch?”  
 See if data from one group agrees with data from another group. Does the 
entire class agree to a single conclusion about how polymer ratio affects gel stiffness? 
Oftentimes there will be conflicting data. Explain that discrepancies do exist in science 
and how improving future experiments (by devising better control and experimental 
conditions) is necessary to advance scientific knowledge. 
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Blood Flow Lab: 
 
Engage (Time: 10) 
 
Explain that the experimental setup models the circulatory system. Ask students to 
hypothesize how vessel stiffness would affect blood flow. 
 
Explore (Time: 25) 
 
Allow students to work through Activity Sheet #2.  
 
Explain (Time: 10) 
 
Work with students to help them answer critical thinking questions. Ask students to 
brainstorm ways they would treat or prevent vessel hardening.  
 
 
 
 
 
 
Supplemental Information: 
1. http://www.sciencebuddies.org/mentoring/project_ideas/Chem_p012.shtml 
2. http://cibt.bio.cornell.edu/labs/dl/BPHY.PDF 
 
Safety:  
Be careful not to get Borax in the eyes. If this happens, please flush eyes with water 
for 10 minutes. 
Students who are allergic to latex should not handle latex. 
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E.1.2 Atherosclerosis lecture slides 
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E.1.3 Elasticity of blood vessels lab 
 
Introduction 
In the circulatory system, blood that is pumped by 
the heart flows through blood vessels and provide 
tissues with nutrients and oxygen. This flow, which 
is created by each heartbeat, is pulsatile; that is, the 
flow created is a series of discontinuous pulses. 
However, for optimal function, our body requires a 
steady, continuous flow of blood. How do blood 
vessels control this? 
 
In addition to controlling blood flow, blood vessels are subject to mechanical 
stress during the pumping of blood. Thus, blood vessels must have mechanical 
properties that can withstand these stresses. Again, the mechanical properties of blood 
vessels are a function of the underlying tissue structure. Since blood vessels are soft 
collagenous tissues (with a good deal of elastin, another biomolecule), their stress-
strain behavior resembles that of other soft collagenous tissues like ligaments and 
tendons. 
Blood vessel tissue structure can change due to aging, disease, or altered 
mechanical load. Sometimes it is a combination of all three factors. For example, 
hypertension or high blood pressure is a 
disease that raises the mechanical load on 
the blood vessel. Due to higher stresses, 
the structure of the blood vessel is altered. 
In disease states such as atherosclerosis, 
arteries lose their elastic properties which 
results in the disruption of continuous 
blood flow. Additionally, blockages of 
blood vessels may lead to aneurysms, 
which are localized balloon-like dilations 
of the vessel. Aneurysms are often fatal if 
they rupture. Therefore, changes in 
mechanical properties may have dire 
consequences! 
 
 
 
Objective 
 
In this lab, we will use various tubing and a ball pump to model the circulatory system 
and observe how the mechanical properties of blood vessels alters blood flow. 
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Materials 
 
• Ball pump and white nozzle 
• 2 pieces of clear, stiff tubing 
• 1 piece of amber, latex tubing 
• 1 piece of pink, latex tubing 
• 2 cable ties 
• 1 beaker  
 
Procedure 
 
1. Fill beaker halfway with water. Set up the circulatory system as follows: Screw the 
white nozzle into the ball pump. Connect the clear tubing to the pump. Then connect 
the amber latex tubing to the clear tubing. Finally, connect the other piece of clear 
tubing to the latex tubing and place the other end into the beaker.  
 
 
 
 
 
2. Briskly pump the ball pump several times. Note how violently the bubbles appear in 
the beaker of water.  What does each pump (down-stroke) represent? 
 
Heartbeat  
 
3. Disassemble the amber latex tubing and now replace it with the thinner pink latex 
tubing. Tie this onto the clear tubing with two cable ties. Make sure the connection is 
air-tight and there is no air leakage. Now pump several times. Do bubbles still form?  
If yes, how do they compare to the amber latex? 
 
Yes, but much less violently. 
 
Which latex tubing results in higher pressure? How do you know? 
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Amber, the bubbles that formed were much more violent, meaning the air 
pressure was much higher. 
 
What happens to the pink tubing during each down-stroke and upstroke? 
 
The swells during the down-stroke and recoils during the upstroke. 
 
In our tube model, which component represents… 
 
 a. the heart? Pump 
 
 b. blood? Air  
 
 c. a healthy artery? Pink latex 
 
 d. an atherosclerotic artery? Amber latex 
 
From your observations, how does the elasticity of a blood vessel affect blood 
pressure?  
 
The less elastic, the higher the blood pressure. 
 
How does the elasticity of a blood vessel control the continuous flow of blood when 
the heart only contracts in pulses? 
 
Elastic vessels can expand during the down-stroke and recoil normally, moving 
blood continuously. Stiff vessels do not expand or recoil so blood moves at higher 
pressures. 
 
4. Empty your beaker into the sink. Now, instead of allowing air to flow into water, 
plug the end of the tubing with your thumb. Now pump several times. What happens to 
the pink latex tubing?  
 
Balloons. 
 
What does your thumb represent?  
 
A thrombus (blood clot) or some kind of occlusion. 
 
 
 
What does the expanded pink latex tubing represent? 
 
An aneurysm. 
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5. Gently squeeze the air-filled pink latex with your fingers. How does this feel 
compared to an unfilled chamber?  
 
Much less elastic due to high pressure. 
 
What can you say about the thickness of the latex as it expands?  
 
Gets thinner. 
 
What about its stiffness? 
 
Stiffer. 
 
Conclusion: 
 
Describe how the function of a blood vessel is altered when the mechanical properties 
of the blood vessel are altered.   
 
Loses its ability to expand and recoil normally, and therefore, its ability to 
regulate blood pressure flow. 
 
If an individual has atherosclerosis what happens to mechanical properties of their 
arteries? 
 
The arteries stiffen. 
 
Explain how atherosclerosis could lead to an aneurysm in a patient. 
 
Fatty plaques can rupture and cause clots that occlude the artery. 
 
How would you design a drug or treatment for atherosclerosis? 
 
A drug that can reverse artery stiffening. A drug that prevents lipids or 
cholesterol from sticking and hardening arteries. A drug that helps the body 
clear plaques. 
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E.1.4 Polymer science: physical properties of gels lab 
 
Introduction 
According to Wikipedia, gels are “jelly-like materials 
that can have properties ranging from soft and weak to 
hard and tough.” They are found in almost all homes in 
different forms. For example, there is probably some 
hair gel in your bathroom. If you are wearing contact 
lenses, then there is a gel sitting on your eyeball. In 
biology labs, scientists can run an electrical current 
through gels in order to separate DNA or protein based 
on their size. Cells can be grown on gels that are 
comprised of various amounts of collagen. 
Gels have many important physical characteristics. One interesting mechanical 
property of gels is their compliance, or stiffness. Obviously, hair gel is less stiff than 
contact lenses. In the growing field of mechanobiology, researchers study how cells 
respond to their mechanical environment by culturing them on soft or stiff gels. This 
kind of research will help to understand how to fight diseases that are caused by 
altered mechanical environments such as atherosclerosis, cancer, and cirrhosis. To 
make gels that have different stiffnesses, scientists vary the ratio of polymer to its 
crosslinker, which is a molecule that bonds one polymer to the next. 
 
Objective 
 
In this lab, we will make gels of varying compliances by altering the ratios of a 
polymer with its crosslinker and examine their physical characteristics.  
 
Materials 
 
• 5 zip lock bags 
• A cup of “solution A” 
• A cup of “solution B” 
• Plastic teaspoons 
• Permanent marker 
• Food coloring 
 
Procedure 
 
1. By varying the ratio of polymer to crosslinker, gel can be made with different 
compliances. To start off, make a gel that has a 4 to 1 ratio of solution A to solution B. 
To accomplish this, label a zip lock bag with “4:1.” Add 4 teaspoons of solution A to 
the bag. Then add 1 teaspoon of solution B to the bag. Zip up the bag and mix 
thoroughly with your fingers. After a few minutes, you should get a gel. Take this out 
of the bag and kneed with your hands. Write down some properties of the gel 
(stiffness, stickiness, bounciness, elasticity, etc.) 
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2. What happens when you pull the gels apart slowly?  
 
Gel stretches. 
 
What happens when you pull the gels apart quickly? 
 
Gel breaks. 
 
Think about the molecular structure of the gel. How do the polymer chains rearrange 
as you pull the gel apart slowly?  
 
Polymer chains align parallel to one another. 
 
How is this different when you pull the gel apart quickly? 
 
There is not enough time to allow for polymer chain alignment. 
 
How does molecular rearrangement of polymer chains affect the gel’s mechanical 
properties? 
 
Polymer alignment gives the gel its elastic strength since all the polymer chains 
are now parallel to one another. They act together similar to rope made of 
individual fibers. 
 
3. Make a ball out of the gel and let it sit on the table for a few minutes. What 
happens? 
 
The gel flattens out. 
 
Would you characterize your gel as a solid or liquid? Why? 
 
Both. It has properties of a solid in that it has structure but is liquid-like since it 
can flow. 
 
 
 
4. From this point on, you will be designing an experiment. Make two to four new 
gels with different ratios of solution A to solution B. Do not go lower than a 2:1 ratio 
or higher than a 10:1 ratio or you will not get a nice gel to play with. Remember to 
label your zip lock bags with the correct ratios! Compare the properties of your new 
gels to the 4:1 ratio gel. 
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5. Based on your observations, how does adding more/less solution A affect gel 
properties? 
 
This depends on the ratios the students choose. Some may find the gels get stiffer 
whereas others find the gels get less stiff. Remember that students may find data 
that do not support one another. Remind groups that discrepancies exist in 
science. Oftentimes this is due to inability to maintain proper controls or 
experimental conditions (such as size of the gel). 
 
6. In science, it is very important to quantify results by using numbers to describe and 
analyze data. Quantify one physical property of your gels as a function of its polymer 
ratio. Write down and explain the procedure of your quantification method. Create a 
chart or graph of this data. To get you started, a sample graph is included. In this 
example, how would you quantify stiffness? (Hint: you can use rulers and/or 
stopwatches)   
 
 
 
ATTACH to your LAB 
 
Examples of experiments:  
 
1. Record the time it takes for a gel to stretch 10 inches when held in mid-air. 
2. Record the length a gel stretches over 30 seconds. 
3. Turn the gel into sphere and measure its initial diameter. Let the ball sit on 
a table for 60 seconds and then measure its diameter. 
4. Turn the gel into a sphere and drop from table height. Record the height 
the ball bounces. 
 
7. If you were to engineer an implantable blood vessel using gels, which mechanical 
2:1 4:1 5:1 9:1 
sti
ffn
es
s 
polymer ratio 
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properties would you consider and why are they important?  
 
They should resemble the stiffness of native blood vessels in that they are not 
very stiff but have enough strength to regulate steady blood flow. They should 
not be sticky or it may lead to disturbed blood flow and the formation of clots. 
E.1.5 Quiz: Atherosclerosis 
 
1. Atherosclerosis occurs primarily in _____________. 
 
A. veins 
B. capillaries 
C. arteries 
D. all of the above 
 
2. Which is considered the first cellular event in the progression of atherosclerosis? 
 
A. Macrophage transformation 
B. Monocyte transmigration 
C. Smooth muscle cell migration 
D. Endothelial cell permeability 
 
3. What type of mechanical stress causes endothelial cells to orient themselves in the 
same direction? 
 
A. hoop/circumferential stress 
B. shear stress 
C. compressive stress 
D. tensile stress 
 
4. In what percent of the population does stiffening of the blood vessels occur? 
 
A. 25% 
B. 40% 
C. 80% 
D. 100% 
 
5. Which is not a risk factor for atherosclerosis? 
 
A. cancer 
B. diabetes 
C. smoking 
D. hypercholesterolemia 
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6. The _____________ of an artery contributes most to its mechanical strength. 
 
A. intima 
B. media 
C. adventitia 
D. lumen 
 
7. Vessel stiffening results in _____________. 
 
A. increased blood pressure 
B. decreased blood pressure 
C. increased cholesterol 
D. laminar blood flow 
 
8. The ratio of stress to strain is called ______________. 
 
A. Young’s modulus 
B. Poisson’s ratio 
C. Creep 
D. Bending strength 
 
9. A liquid polymer solution can easily be turned into a gel by adding __________. 
 
A. a detergent 
B. an emulsifier 
C. a crosslinker 
D. an organic solvent 
 
10. Blood vessels are similar to gels in that they act as _____________ materials. 
 
A. viscoelastic 
B. elastic 
C. isotropic 
D. compressible 
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E.2 Cell-Cell communications lecture slides 
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E.3 Bioterrorism lecture slides 
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E.4 Cancer lecture slides 
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E.5 Heart valves lecture slides 
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E.6 Nanotechnology lecture slides 
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E.7 Tissue engineering lecture slides 
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APPENDIX F 
 
VASCULAR ENDOTHELIAL (VE)-CADHERIN WIDTH MEASUREMENTS 
 
Protocol: 
1. Open image in ImageJ. 
2. Draw a line across the widest gap per junction perpendicular to the junction. 
3. Press ‘k’ to pull up the pixel intensity profile of the line just drawn. 
4. Save the graph values by clicking ‘Save…’ and saving with the naming 
convention data001.dat, data002.dat, etc. 
5. Once all of the lines are saved, place all data files in the same folder. Also 
place mainpixel3.m and PixelSSR2.m into the same folder. 
6. Open MATLAB. Set your ‘Current Folder’ as the folder with all of your data 
files. 
7. Edit line 7 of mainpixel3.m to match the number of data files you have. Edit 
line 41 if necessary to account for microscope objective magnification. 
8.  Run mainpixel3.m.  
9. Go through the figures MATLAB generated. If there are plots where the fit is 
incorrect, edit lines 24 through 27 by changing i and the guesses for 
fminsearch. Additional if-statements can be added for additional incorrect fits. 
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1 %mainpixel3.m 
2 %this program fits to TWO gaussians 
3 %put files into same directly as program, with naming scheme: 
4 %data001.dat, data002,dat etc. No text on first line, just # 
5 clear 
6 global data  
7 Nfiles=60;   %number of files, maximum is 999 
8 for i=1:Nfiles 
9  
10    num=num2str(i); 
11    if length(num)==1 
12        filename=['data00',num,'.dat']; 
13    elseif length(num)==2 
14        filename=['data0',num,'.dat']; 
15    else 
16        filename=['data',num,'.dat']; 
17    end 
18    load(filename) 
19    data=eval(filename(1:7)); 
20     
21    A=fminsearch('PixelSSR2',[18,25,4,500,120], 
      optimset('MaxFunEvals', 5000,'MaxIter', 5000)); 
22    %A1=mu1, A2=mu2, A3=sig, A4=a1 (rescale), A5=a2 (baseline) 
23  
24    if (i==61) 
25    A=fminsearch('PixelSSR2',[14,25,4,500,250],  
      optimset('MaxFunEvals', 5000,'MaxIter', 5000)); 
26        checkme=i 
27    end 
28   
29    x=[1:.1:length(data)]; 
30    figure(i) 
31    plot(data(:,1),data(:,2),'bo',x,... 
32        A(4).*(1/sqrt(2*pi*A(3).^2)*exp(-(x- 
          A(1)).^2/(2*A(3).^2))+... 
33    1/sqrt(2*pi*A(3).^2)*exp(-(x-A(2)).^2/(2*A(3).^2)))+A(5),'r-') 
34  
35    if (A(1)<1 | A(2)<1 | A(1)>length(data) | A(2)>length(data) ) 
36        A6=A(3)*3.585; %the width at 20% above baseline is  
                         =3.585*sigma+abs(mu1-mu2) 
37        A(2)=A(1); % added 
38    else 
39        A6=A(3)*3.585+abs(A(1)-A(2)); 
40    end 
41    A6=A6*0.3225; % for 20x images on the fluorescent scope 
42    A7=abs(A(1)-A(2)); 
43    A8=A7./A(3); 
44    Alarge(i,:)=[A,A6,A7,A8]; 
45  
45     
47 end 
48 %these numbers can be used to recreate the Gaussian curves. 
49 %columns: mu1 | mu2 | sigma | rescale | baseline | width | Dmu |  
   Dmu/sigma 
50 saving_results=xlswrite('widths.xls', Alarge); 
 199 
51   
52 avg_width_at_20_percent_in_um=mean(Alarge(:,6)) 
 
 
 
 
1 % PixelSSR2.m 
2 % fit pixel intensity data to 2 Gaussian functions of the form: 
3 % f = a1*(1/sqrt(2*pi*sig^2)*exp(-(x-mu1)^2/(2*sig^2))+... 
4 % 1/sqrt(2*pi*sig^2)*exp(-(x-mu2)^2/(2*sig^2))) + a2 
5 %we are constraining the two sigmas to be equal 
6 %a1 rescales the distribution and a2 is the baseline 
7 
8  function SSR = PixelSSR(A) 
9  global data 
10 mu1=A(1);    mu2=A(2);   sig=A(3);   a1=A(4);    a2=A(5); 
11  
12 SSR=sum((data(:,2)-a1.*(1/sqrt(2*pi*sig.^2)*exp(-(data(:,1)- 
13 mu1).^2/(2*sig.^2))+... 
14 1/sqrt(2*pi*sig.^2)*exp(-(data(:,1)-mu2).^2/(2*sig.^2)))-a2).^2); 
 
 
